Document:

ASSET
PURCHASE AGREEMENT

 

THIS
ASSET PURCHASE AGREEMENT (the “Agreement”) is made as of May 9, 2016 by and between MGT Cybersecurity Inc.,
a Delaware corporation (the “Buyer”), MGT Capital Investments, Inc., a Delaware corporation (“Parent”)
and D-Vasive, Inc., a Wyoming corporation (“D-Vasive”), and the shareholders of D-Vasive, Inc. identified on
the signature page hereto (together with D-Vasive, the “Sellers”).

 

RECITALS

 

WHEREAS,
D-Vasive is in the business of development and marketing of certain privacy and anti-spy applications (the “Business”),
and owns certain intellectual property and other assets related to the Business;

 

WHEREAS,
D-Vasive desires to sell, and Buyer, a wholly owned subsidiary of Parent, desires to purchase, on the terms and subject to the
conditions of this Agreement, certain assets of the Business;

 

NOW,
THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements herein contained,
and intending to be legally bound, the Parties hereto agree as follows:

 

ARTICLE
I

DEFINITIONS

 

“Action”
means any litigation, written claim threatening any third-party adjudication of a dispute, suit, arbitration, mediation, inquiry,
investigation, government investigation, regulatory proceeding or other proceeding of any nature (whether criminal, civil, legislative,
administrative, regulatory, prosecutorial or otherwise) by or before any arbitrator or Government Body or similar Person or body.

 

“Affiliate”
of any Person means any Person that controls, is controlled by, or is under common control with such Person. As used herein, “control”
means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of
such entity, whether through ownership of voting securities or other interests, by contract or otherwise.

 

“Agreement”
means this asset purchase agreement.

 

“Assets”
shall have such meaning as set forth in Section 2.1.

 

“Assumed
Liabilities” shall have such meaning as set forth in Section 2.3.

 

“Bill
of Sale, Assignment and Assumption Agreement” shall have such meaning as set forth in Section 3.2(i).

 

“Business”
shall have the meaning as set forth in the recitals.

 

“Buyer”
shall have the meaning as set forth in the recitals.

 

“Buyer’s
Consents” shall have the meaning as set forth in Section 5.3(d).

 

“Bylaws”
shall have such meaning as set forth in Section 5.2(c).

 

    	 	 

    	 

    

 

“Certificate
of Incorporation” shall have such meaning as set forth in Section 5.2(c).

 

“Closing”
shall have such meaning as set forth in Section 3.1.

 

“Closing
Date” shall have such meaning as set forth in Section 2.4.

 

“Closing
Cash” ” shall have such meaning as set forth in Section 3.1.

 

“Code”
means the Internal Revenue Code of 1986, as amended.

 

“Collateral
Agreements” means all such concurrent or subsequent agreements, documents and instruments, as amended, supplemented,
or otherwise modified in accordance with the terms hereof or thereof, including without limitation the Bill of Sale, the Escrow
Agreement and the IP Assignment.

 

“Common
Stock” means shares of common stock, par value $0.0001 per share, of the Parent.

 

“Employment
Agreements” shall have such meaning as set forth in Section 3.2(xi).

 

“Consulting
Agreement” shall have such meaning as set forth in Section 3.2(xi)

 

“Contracts”
means all contracts, agreements, leases, subleases, licenses, sublicenses, commitments, indemnities, assignments, understandings
and arrangements, whether written or oral, that are legally enforceable.

 

“Contributing
IP” shall have such meaning as set forth in Section 4.12(J).

 

“Demand
Letters” shall have such meaning as set forth in Section 4.12(f)

 

“D-Vasive”
shall have the meaning as set forth in the recitals.

 

“D-Vasive
Consents” shall have such meaning as set forth in Section 4.3(d).

 

“D-Vasive
Offerings” means any products or services developed, manufactured, offered, provided, sold or otherwise distributed
by or for D-Vasive related to the Business.

 

“Encumbrance”
means any mortgage, pledge, security interest, hypothecation, assignment, or lien.

 

“Environmental
Law” shall mean any Law which relates to or otherwise imposes liability or standards of conduct concerning discharges,
emissions, releases or threatened releases of noises, pathogens, odors, pollutants, or contaminants or hazardous or toxic wastes,
substances or materials, whether as matter or energy, into air (whether indoors or out), water (whether surface or underground)
or land (including any subsurface strata), or otherwise relating to their manufacture, processing, generation, distribution, use,
treatment, storage, disposal, cleanup, transport or handling, including the Comprehensive Environmental Response, Compensation
and Liability Act of 1980, as amended, the Superfund Amendments and Reauthorization Act of 1986, as amended, the Resource Conservation
and Recovery Act of 1976, as amended, the Toxic Substances Control Act of 1976, as amended, the Federal Water Pollution Control
Act Amendments of 1972, the Clean Water Act of 1977, as amended, the National Environmental Policy Act of 1969, and any state
provision analogous to any of the foregoing.

 

    	 	 

    	 

    

 

“Escrow
Agent” shall mean an escrow agent to be mutually agreed by the Parties prior to Closing .

 

“Escrow
Agreement” shall mean an escrow agreement dated of even date herewith by and among the Parties and the Escrow Agent
(“the “Escrow Agreement”).

 

“Escrow
Period” means a period of [twelve (12)] months, commencing on the Closing Date.

 

“Escrow
Shares” shall have such meaning as set forth in Section 2.4.

 

“Excluded
Assets” shall have such meaning as set forth in Section 2.1.

 

“GAAP”
shall have such meaning as set forth in Section 5.5.

 

“Governmental
Body” means any nation or government, any state or other political subdivision thereof, any legislative, executive or
judicial unit or instrumentality of any government entity (foreign, federal, state or local) or any department, commission, board,
agency, bureau, official or other regulatory, administrative or judicial authority thereof or any entity (including a court or
self-regulatory organization) exercising executive, legislative or judicial, Tax, regulatory or administrative functions of or
pertaining to government.

 

“Hazardous
Substance” means any material, substance, form of energy or pathogen which (a) constitutes a “hazardous substance”,
“toxic substance” or “pollutant”, “contaminant”, “hazardous material”, “hazardous
chemical”, “regulated substance”, or “hazardous waste” (as such terms are defined by or pursuant
to any Environmental Law) or (b) is otherwise regulated or controlled by, or gives rise to liability under, any environmental
law.

 

“Indemnified
Party” means any party entitled to receive indemnification hereunder.

 

“Indemnifying
Party” means any party obligated to provide indemnification hereunder.

 

“Intellectual
Property” means all domestic or foreign rights in, to and concerning: (i) inventions and discoveries (whether patented,
patentable or unpatentable and whether or not reduced to practice), including ideas, research and techniques, technical designs,
and specifications (written or otherwise), improvements, modifications, adaptations, and derivations thereto, and patents, patent
applications, inventor’s certificates, and patent disclosures, together with divisions, continuations, continuations-in-part,
revisions, reissuances and reexaminations thereof; (ii) trademarks, service marks, brand names, certification marks, collective
marks, d/b/a’s, trade dress, logos, symbols, trade names, assumed names, fictitious names, corporate names and other indications
or indicia of origin, including translations, adaptations, derivations, modifications, combinations and renewals thereof; (iii)
published and unpublished works of authorship, whether copyrightable or not (including databases and other compilations of data
or information), copyrights therein and thereto, moral rights, and rights equivalent thereto, including but not limited to, the
rights of attribution, assignation and integrity; (iv) trade secrets, confidential and/or proprietary information (including ideas,
research and development, know-how, formulas, compositions, manufacturing and production processes and techniques, technical data,
schematics, designs, discoveries, drawings, prototypes, specifications, hardware configurations, customer and supplier lists,
financial information, pricing and cost information, financial projections, and business and marketing methods plans and proposals),
collectively “Trade Secrets”; (v) computer software, including programs, applications, source and object code,
data bases, data, models, algorithms, flowcharts, tables and documentation related to the foregoing; (vi) other similar tangible
or intangible intellectual property or proprietary rights, information and technology and copies and tangible embodiments thereof
(in whatever form or medium); (vii) all applications to register, registrations, restorations, reversions and renewals or extensions
of the foregoing; (viii) internet domain names; and (ix) all the goodwill associated with each of the foregoing and symbolized
thereby; and (x) all other intellectual property or proprietary rights and claims or causes of action arising out of or related
to any infringement, misappropriation or other violation of any of the foregoing, including rights to recover for past, present
and future violations thereof.

 

    	 	 

    	 

    

 

“IP
Assignment” shall have such meaning as set forth in Section 3.2(x).

 

“IP
Claims” means any and all claims and causes of action, whether asserted or unasserted, of D-Vasive against third parties
related to the Intellectual Property being sold, transferred and assigned hereunder to Buyer.

 

“Knowledge”
or “knowledge” means, with respect to Sellers, the actual knowledge of Sellers, and with respect to Buyer and
Parent, the actual knowledge of Felicia Hess, Daniyel Erdberg and Kevin Hess.

 

“Law”
or “Laws” means any law, statute, ordinance, rule, regulation, code, order, judgment, Tax ruling, injunction,
decision or decree of any Governmental Body.

 

“Licenses”
means any licenses, registrations or certificates granted to D-Vasive by any Governmental Body as required by applicable Law.

 

“License
Agreements” shall have such meaning as set forth in Annex A of the Escrow Agreement.

 

“Material
Adverse Effect” means, with respect to a Party any change, event or occurrence that is, or is reasonably likely to be
or become, materially adverse to (a) the property, business, operations assets (tangible and intangible) or financing condition
of such Party, or (b) the ability of a Party to consummate the transactions contemplated by this Agreement and the Collateral
Agreements or to perform its material obligations hereunder or thereunder, respectively; provided, that none of the following
shall be deemed, either alone or in combination, to constitute a Material Adverse Effect: (i) conditions, changes or effects that
generally affect any of the industries or markets in which D-Vasive or Buyer, as the context requires, operates, or the United
States economy or securities or financial markets in general, (ii) any change in any Law, (iii) any formal change by a Governmental
Body in the interpretation of any applicable Law that takes effect after the date of this Agreement, or (iv) any change resulting
from compliance by such Party with the terms of, or the taking of any action contemplated or permitted by, this Agreement.

 

“Parent”
shall have the meaning as set forth in the recitals.

 

“Party”
means Buyer, Parent or a Seller.

 

“Parties”
means Buyer, Parent and Sellers, collectively.

 

“Permitted
Encumbrances” means (a) liens for Taxes not yet due and payable or being contested in good faith, (b) mechanics’,
carriers’, workmen’s, repairmen’s or other like liens arising or incurred in the ordinary course of business
consistent with past practice or amounts that are not delinquent and which are not, individually or in the aggregate, material
to the Business or the Assets, or (c) liens arising under original purchase price conditional sales contracts and equipment leases
with Third Parties entered into in the ordinary course of business consistent with past practice which are not, individually or
in the aggregate, material to the Business or the Assets.

 

    	 	 

    	 

    

 

“Permits”
means all material permits, licenses, certificates, approvals, qualifications, registrations, and similar authorizations issued
to D-Vasive by a Governmental Body related to the Assets or Purchased Contracts, including any amendment, modification, limitation,
condition or renewal thereof.

 

“Person”
means any individual, corporation, partnership, limited liability company, limited liability firm, association, joint venture,
joint stock company, trust, unincorporated association or other entity, or any Governmental Body.

 

“Personal
Information” means information from or about an individual that is sufficient to identify such individual, including,
but not limited to, an individual’s: first and last name, home or other physical address; telephone number, including home
telephone number and mobile telephone number, email address or other contact information; financial account number, government-issued
identifier, or persistent identifier, such as IP address or other unique identifier with another piece of information that would
permit the identification of a Person; list of contacts, provided that the list permitted specific identification of those on
such list; sufficiently precise physical location; or any other information from or about an individual consumer that is combined
with information from or about an individual that is sufficient to identify such individual.

 

“Purchase
Price” shall have such meaning as set forth in Section 2.5.

 

“Purchased
Contracts” shall have such meaning as set forth in Section 2.2.

 

“Registered
IP” means all Intellectual Property rights that are registered or filed with or issued by any Governmental Body, including
all patents, registered copyrights, registered mask works, and registered trademarks and all applications for any of the foregoing.

 

“Registered
IP Fees” shall have such meaning as set forth in Section 4.12(c).

 

“SEC
Documents” shall have such meaning as set forth in Section 5.5.

 

“Sellers”
shall have the meaning as set forth in the recitals.

 

“Software”
means all (i) computer programs and other software, including software implementations of algorithms, models, and methodologies,
whether in source code, object code or other form, including libraries, subroutines and other components thereof, (ii) computerized
databases and other computerized compilations and collections of data or information, including all data and information included
in such databases, compilations or collections, (iii) screens, user interfaces, command structures, report formats, templates,
menus, buttons and icons, (iv) descriptions, flow-charts, architectures, development tools, and other materials used to design,
plan, organize and develop any of the foregoing and (v) all documentation, including development, diagnostic, support, user and
training documentation related to any of the foregoing.

 

“Tax
Returns” means all returns, information returns, reports, declarations, or other filings required to be made with any
Governmental Body with respect to Taxes.

 

“Taxes”
mean all taxes of any kind, charges, fees, customs, levies, duties, imposts, required deposits or other assessments, including
all net income, capital gains, gross income, gross receipt, property, franchise, sales, use, excise, ad valorem, value added,
transfer, gains, profits, license, net worth, asset, transaction, and other taxes, imposed upon any Person by any Law or Governmental
Body, together with any interest and any penalties, or additions to tax, with respect to such taxes.

 

“Third
Party” means any Person other than, and not an Affiliate of, a Party.

 

    	 	 

    	 

    

 

ARTICLE
II

PURCHASE
AND SALE OF ASSETS

 

2.1.Purchase
and Sale of Assets. Subject to the terms and conditions of this Agreement, at the Closing, D-Vasive agrees to sell, convey
and assign to Buyer, and Buyer agrees to purchase from D-Vasive, free and clear from all Encumbrances (other than Permitted Encumbrances),
all of D-Vasive’s right, title and interest in, to and under the assets of D-Vasive used or held for use in the Business
at Closing, including those assets specified below (which are hereinafter collectively referred to as the “Assets”),
but specifically excluding the Excluded Assets (defined below):

 

(a)customer
contracts, databases, sales pipeline, proposals of the Business, and project files associated with the Business;

 

(b)all
Licenses and Permits of the Business, to the extent transferable to Buyer;

 

(c)the
assets to be transferred pursuant to the IP Assignment;

 

(d)all
social media accounts used by D-Vasive in the conduct of the Business, including all user names and passwords associated with
such social media accounts.

 

(e)all
Purchased Contracts, including but not limited to the accounts with any Third Party provider enabling the Business’ website
and/or application, to the extent the contracts associated with those accounts are assignable; and

 

(f)all
rights, IP Claims and causes of action against third parties resulting from or relating to the operation of the Business and the
Assets prior to the Closing Date, including without limitation, any rights, claims and causes of actions arising under warranties
from vendors and other third parties and the proceeds of insurance.

 

“Excluded
Assets” shall mean the following assets of Sellers that will be retained by Sellers and are not being sold or assigned
to Buyer hereunder: (i) all taxpayer and other identification numbers and minute books, stock transfer books and other documents
relating to the organization, maintenance, and existence of D-Vasive as a legal entity; (ii) Sellers’ rights under this
Agreement and the agreements to be executed by Sellers in connection herewith; and (iii) such other assets of D-Vasive as are
specifically listed on Schedule 2.1.

 

2.2.Assignment
of Contracts. Upon the terms and subject to the conditions of this Agreement, at the Closing, D-Vasive shall assign and transfer
to Buyer, and Buyer shall assume and take assignment of, the Contracts listed on Schedule 2.2 hereto (collectively, the
“Purchased Contracts”) subject to Third Party consents, which may be later obtained in accordance with the
Escrow Agreement. Sellers shall take or cause to be taken all actions reasonably necessary to receive all required consents from
Third Parties to the assignment of the Purchased Contracts. Buyer shall not be obligated to assume any Purchased Contracts which
require consent to assignment unless such consent has been obtained.

 

2.3.Liabilities.
Except as provided for herein, Buyer will not assume any liabilities of Sellers. Excluded liabilities (the “Excluded
Liabilities”) shall include, without limitation, the following:

 

    	 	 

    	 

    

 

(a)liabilities
arising from Sellers’ breaches, defaults or failures of performance (i) under the Purchased Contracts; (ii) under contracts
not included in the Purchased Contracts, including but not limited to any leases for the rental of any real property; or (iii)
the operation of the Business, arising out of events occurring on or before the Closing;

 

(b)any
liabilities for Taxes incurred or accrued by Sellers, including but not limited to payroll, sales, income, and any Taxes that
become due as a result of the transactions contemplated by this Agreement;

 

(c)any
debt, payables or other liabilities, including without limitation any equipment or other leases (operating, capitalized or otherwise),
any 401(k), profit sharing or pension plan, any deferred compensation payables, accrued bonus, payroll or vacation payables, or
COBRA-related obligations;

 

(d)any
litigation, dispute or Action pending or threatened against Sellers (or its shareholders or management as applicable); and any
warranty liability to customers arising out of events occurring on or before the Closing Date;

 

(e)accrued
interest on any debt obligations of the Sellers; and

 

(f)any
liabilities not related to the Business.

 

Notwithstanding
the foregoing, as part of the consideration for the Assets, Buyer shall assume on the Closing Date only those obligations of Sellers
to be performed after the Closing under those Purchased Contracts, Licenses and Permits constituting Assets, but excluding any
obligations or liabilities arising from any performance, omissions, activities or events related to any such Purchased Contract,
License or Permit occurring on or prior to the Closing (the “Assumed Liabilities”).

 

2.4.Purchase
Price. Subject to the terms and conditions set forth in Section 2.5, in consideration for the sale, transfer, assignment,
conveyance and delivery by D-Vasive to Buyer of the Assets and Sellers’ agreement to retain and satisfy the Excluded Liabilities,
Parent shall (i) pay to Sellers Three Hundred Thousand U.S. Dollars ($300,000), less Registered IP Fees due and unpaid by D-Vasive
at Closing unless otherwise agreed upon by the Parties (the “Closing Cash”), (ii) issue to Sellers of Seller’s
designees(s), and deliver to Escrow Agent four million and seven hundred and sixty thousand (4,760,000) unregistered shares of
Common Stock (the “Escrow Shares”) to be held in escrow in accordance with the Escrow Agreement and subject
to adjustment, in accordance with the Escrow Agreement; and (iii) issue and delivery to Sellers or Sellers’ designees(s)
nineteen million and forty thousand (19,040,000) unregistered shares of Common Stock (the “Closing Shares”
together with Escrow Shares as “Purchase Price Shares”) The Closing Cash, the Escrow Cash and Closing Shares
are collectively referred to as the “Purchase Price”. The Purchase Price Shares shall be allocated to Sellers
according to Annex A.

 

2.5.Escrow;
Lockup.

 

(a)The
Escrow Shares shall represent shares otherwise transferable by D-Vasive to certain shareholders or creditors of D-Vasive and be
available to secure any claims that may arise with respect to the representations, warranties, covenants or indemnification obligations
of Sellers pursuant to this Agreement during the Escrow Period. Furthermore, the Escrow Shares shall be surrendered for cancellation
to the Parent upon the failure to obtain certain milestones set forth in the Escrow Agreement.

 

    	 	 

    	 

    

 

(b)All
of the Purchase Price Shares shall be subject to the obligation by D-Vasive or D-Vasive’s designees, for a period of [twelve
(12)] months following the Closing Date, not to offer, sell, offer to sell, contract to sell, hedge, pledge, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or sell, or otherwise
transfer or dispose of any securities of the Parent pursuant to the Lockup Agreement in the form attached hereto as Exhibit
B (the “Lockup Agreement”), which Lockup Agreement D-Vasive agrees to require any of the D-Vasive’s
designees to assume prior to becoming the registered holder of such Purchase Price Shares.

 

ARTICLE
III

CLOSING

 

3.1.Closing.
Unless this Agreement is earlier terminated in accordance with Section 3.4, the closing of the transactions contemplated
by this Agreement (the “Closing”) shall take place such date when each of the conditions set forth in this
Article III have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the
Closing, but subject to the fulfillment or waiver of those conditions), or at such other time as the Parties may agree (the “Closing
Date”). The Closing shall take place remotely by the electronic exchange of documents and signatures, or at such location
as the Parties hereto agree.

 

3.2.Conditions
to Closing.

 

(a)
Conditions to Obligations Common to Both Parties. The respective obligations of each Party hereto to consummate the transactions
contemplated hereby shall be subject to the satisfaction at or prior to the Closing of each of the following conditions:

 

(i)
No temporary restraining order, preliminary or permanent injunction or other order issued by any court of competent jurisdiction
or other legal or regulatory restraint or prohibition preventing the consummation of the Asset Purchase shall be in effect, nor
shall any action have been taken by any Governmental Authority seeking any of the foregoing, and no statute, rule, regulation
or order shall have been enacted, entered, enforced or deemed applicable to the Asset Purchase, which makes the consummation of
the Asset Purchase illegal; and

 

(ii)
Buyer and Seller shall have timely obtained from each Governmental Authority, including NYSE MKT, all approvals, waivers and consents,
if any, necessary for consummation of, or in connection with, the Asset Purchase and the other transactions contemplated hereby.

 

(b)
Additional Conditions to Obligations of Seller. The obligations of Seller to consummate the transactions contemplated hereby
shall be subject to the satisfaction at or prior to the Closing of each of the following conditions (it being understood that
each such condition is solely for the benefit of Seller and may be waived by Seller in writing in its sole discretion without
notice, liability or obligation to any Person):

 

(i)
The representations and warranties of Buyer in this Agreement shall be true and correct in all material respects (except for such
representations and warranties that are qualified by their terms by a reference to materiality, which representations and warranties
as so qualified shall be true and correct in all respects) on and as of the Agreement Date and on and as of the Closing Date as
though such representations and warranties were made on and as of such date (except for representations and warranties which address
matters only as to a specified date, which representations and warranties shall be true and correct with respect to such specified
date). Buyer shall have performed and complied in all material respects with all covenants, obligations and conditions of this
Agreement required to be performed and complied with by it at or prior to the Closing.

 

    	 	 

    	 

    

 

(ii)
Seller shall have received each of the deliverables required to be made by Buyer to Seller pursuant to Section 3.3.

 

(c)
Additional Conditions to Obligations of the Buyer. The obligations of the Buyer to consummate the transactions contemplated
hereby shall be subject to the satisfaction at or prior to the Closing of each of the following conditions (it being understood
that each such condition is solely for the benefit of the Buyer and may be waived by the Buyer in writing in its sole discretion
without notice, liability or obligation to any Person):

 

(i)
The representations and warranties of Seller in this Agreement shall be true and correct in all material respects (except for
such representations and warranties that are qualified by their terms by a reference to materiality, which representations and
warranties as so qualified shall be true and correct in all respects) on and as of the Agreement Date and on and as of the Closing
Date as though such representations and warranties were made on and as of such date (except for representations and warranties
which address matters only as to a specified date, which representations and warranties shall be true and correct with respect
to such specified date). Seller shall have performed and complied in all material respects with all covenants, obligations and
conditions of this Agreement required to be performed and complied with by it at or prior to the Closing.

 

(ii)
Buyer shall have received each of the deliverables required to be made by Seller to Buyer pursuant to Section 3.3.

 

(iii)
There shall not have occurred a Material Adverse Effect with respect to the Purchased Assets since the Agreement Date.

 

(iv)
Seller shall have delivered pro forma financial statements of the Business (either auditable or audited by a PCAOB qualified
auditing firm).

 

3.3.Closing
Deliverables. 

 

 (a) At the Closing, Seller shall deliver to Buyer

 

i.a
bill of sale, assignment and assumption for the Assets in the form attached as Exhibit C hereto (the “Bill
of Sale”) duly executed by D-Vasive;

 

ii.assignments
in the form of Exhibit D hereto transferring all of D-Vasive’s right, title and interest in and to D-Vasive
Intellectual Property to be transferred to Buyer pursuant to this Agreement to Buyer duly executed by D-Vasive (the “IP
Assignment”);

 

iii.duly
executed Escrow Agreement;

 

iv.such
other instruments of assignment, transfer and conveyance as Buyer shall reasonably request to transfer to and vest in Buyer all
of D-Vasive’s right, title and interest in, to and under the Assets;

 

    	 	 

    	 

    

 

v.evidence
of the receipt of D-Vasive Consents or, if applicable, evidence of communications requesting a Third Party to provide consent
required to be obtained by D-Vasive pursuant to this Agreement and subject to the Escrow Agreement;

 

vi.any
Uniform Commercial Code termination statements, releases and other documents necessary to evidence that each of the Assets is
being sold, conveyed, transferred, assigned and delivered to Buyer free and clear of any Encumbrances (except for Permitted Encumbrances),
as set forth on Schedule 3.3(iv);

 

vii.Seller
shall deliver, cause to be delivered, or make available in a manner satisfactory to the Buyer, the source code underpinning the
D-Vasive application and other Software developed by Seller in connection with the Business;

 

viii.
the book and records solely related to the Assets;

 

ix.copies
of the following, in each case certified as of the Closing Date by the Secretary of D-Vasive: (1) resolutions of D-Vasive’s
board and shareholders authorizing the execution, delivery and performance of this Agreement and the other agreements that D-Vasive
is required to execute and deliver pursuant to the terms of this Agreement; and (2) the signature and incumbency of the Persons
authorized to execute and deliver this Agreement and the other agreements and certificates that D-Vasive is required to execute
and deliver pursuant to the terms of this Agreement; and

 

x.a
certificate dated as of the Closing Date, executed on behalf of Seller by its executive officer, to the effect that (i) the condition
set forth in Section 3.2(c)(i) has been satisfied, and (ii) there shall not have occurred a Material Adverse Effect with
respect to the Assets since the Agreement Date;

 

xi.employment
agreements, in the form of Exhibit E hereto (the “Employment Agreements”), duly executed by each
of John McAfee, Louis Franco and John Thomas Clore,

 

xii.a
consulting agreement, in the form of Exhibit F hereto, duly executed by Future Tense Secure Systems Inc.;

 

xiii.duly
executed Lockup Agreement; and

 

xiv.duly
executed written consent from John McAfee authorizing the Company to use “John McAfee” in the Company’s name
indefinitely without any compensation.

 

Simultaneous
with the deliveries referred to in this Section 3.2, Sellers shall take or cause to be taken all such actions as may reasonably
be required to put Buyer in actual possession and operating control of the Assets. To the extent deliveries required under Section
3.2 are not made, Buyer (in its sole discretion) may waive such requirement; but if such requirement is not waived, Sellers shall
cooperate in any reasonable arrangement proposed by Buyer designed to obtain for Buyer the material benefits and privileges of
such deliveries not made.

 

    	 	 

    	 

    

 

(b)
At the Closing, Buyer shall deliver to Seller:

 

i.a
certificate dated as of the Closing Date, executed on behalf of Buyer by its President, to the effect that the condition set forth
in Section 3.2(b)(i) has been satisfied;

 

ii.
evidence that the approval from NYSE MKT has been obtained;

 

iii.in
immediately available funds the Closing Cash to Seller;

 

iv.certificate(s)
of Common Stock representing the Closing Shares;

 

v.certificate(s)
of Common Stock representing the Escrow Shares to the Escrow Agent;

 

vi.Employment
Agreements duly executed by Parent;

 

vii.the
Bill of Sale duly executed by Buyer;

 

viii.the
Escrow Agreement duly executed by Buyer and Parent; and

 

ix.Buyer
shall deliver copies of the following, in each case certified as of the Closing Date by the Secretary or Assistant Secretary of
Buyer or the Parent, as may be the case: (1) resolutions of Buyer’s and Parent’s board of directors authorizing the
execution, delivery and performance of this Agreement and the other agreements that Buyer is required to execute and deliver pursuant
to the terms of this Agreement; and (2) the signature and incumbency of the Persons authorized to execute and deliver this Agreement,
the other agreements and certificates Buyer is required to deliver pursuant to this Agreement.

 

3.4.Termination.
At any time prior to the Closing, this Agreement may be terminated and the transactions contemplated hereby abandoned by authorized
action taken by the terminating Party:

 

(a)
by mutual written consent duly authorized by Buyer and Seller;

 

(b)
by either Buyer or Seller, if the Closing shall not have occurred on or before September 8, 2016 or such other date that Buyer
and Seller may agree upon in writing (the “Termination Date”); provided, however, that the right
to terminate this Agreement under this Section 3.4(b) shall not be available to any Party whose breach of this Agreement
has resulted in the failure of the Closing to occur on or before the Termination Date;

 

(c)
by either Buyer or Seller, if any permanent injunction or other order of a Governmental Authority preventing the consummation
of the transactions contemplated hereby shall have become final and nonappealable;

 

(d)
by Buyer, if Seller shall have breached any representation, warranty, covenant or agreement contained herein and such breach shall
not have been cured within five business days after receipt by Seller of written notice of such breach (provided, however,
that no such cure period shall be available or applicable to any such breach which by its nature cannot be cured) and if not cured
within the timeframe above and at or prior to the Closing, such breach would result in the failure of any of the conditions set
forth in Section 3.2(c) to be satisfied; or

 

    	 	 

    	 

    

 

(e)
by Seller, if Buyer shall have breached any representation, warranty, covenant or agreement contained herein and such breach shall
not have been cured within five business days after receipt by Buyer of written notice of such breach (provided, however,
that no such cure period shall be available or applicable to any such breach which by its nature cannot be cured) and if not cured
within the timeframe above and at or prior to the Closing, such breach would result in the failure of any of the conditions set
forth in Section 3.2(b) to be satisfied.

 

3.5.Effect
of Termination. In the event of termination of this Agreement as provided in Section 3.4, this Agreement shall forthwith
become void and there shall be no liability or obligation on the part of the Buyer, Parent, Seller, or their respective officers,
directors, stockholders or affiliates; provided, however, that the provisions of this Section 3.5 and Article
VIII (Miscellaneous) shall remain in full force and effect and survive any termination of this Agreement.

 

ARTICLE
IV

REPRESENTATIONS AND WARRANTIES OF SELLERS

 

Except
as set forth in the Schedules attached hereto, Sellers represent and warrant to Buyer and Parent that the statements contained
in this Article IV are true and correct as of the date hereof.

 

4.1.Organization
and Qualification. D-Vasive is a corporation duly organized, validly existing and in good standing under the laws of the State
of Wyoming. D-Vasive has all requisite power and authority to own, lease and license the Assets as such Assets are currently owned,
operated, leased or licensed, and to operate the Business as such Business is currently operated.

 

4.2.Authorization;
Binding Effect.

 

(a)Subject
to obtaining board and/or shareholder approval of this Agreement prior to Closing, each Seller has all requisite power and authority
to execute and deliver this Agreement and each Collateral Agreement to which it is or will be a party and to effect the transactions
contemplated hereby and thereby. The execution, delivery and performance by D-Vasive of this Agreement and each Collateral Agreement
to which it is or will be a party and the consummation by D-Vasive of the transactions contemplated hereby and thereby have been
duly and validly approved by D-Vasive’s shareholders and board of directors, and no other company actions or proceedings
on the part of D-Vasive or any Affiliate of D-Vasive are necessary to authorize the execution, delivery and performance by D-Vasive
of this Agreement or the Collateral Agreements to which it is or will be a party or the transactions contemplated hereby and thereby
save and except shareholder approval.

 

(b)Sellers
have duly and validly executed and delivered this Agreement. When this Agreement and each of the Collateral Agreements to which
Sellers are or will be a Party have been duly executed and delivered by Sellers (assuming due execution by Buyer, Parent and any
party to such agreements other than Sellers), this Agreement and each such Collateral Agreement will constitute valid and legally
binding obligations of Sellers, enforceable against Sellers in accordance with their respective terms, except as such agreements
may be subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws and equitable
principles relating to or affecting or qualifying the rights of creditors generally and general principles of equity.

 

    	 	 

    	 

    

 

4.3.Non-Contravention;
D-Vasive Consents. The execution, delivery and performance of this Agreement and the applicable Collateral Agreements by Sellers,
and the consummation of the transactions contemplated hereby and thereby do not and will not:

 

(a)conflict
with or result in a breach or violation of any provision of any organizational documents of D-Vasive, it being expressly understood
that D-Vasive is required to obtain a consent from its shareholders authorizing the transactions contemplated hereunder, which
consent shall be obtained prior to the Closing Date;

 

(b)violate,
or result in a breach of, or constitute an occurrence of default under any provision of, result in the acceleration or cancellation
of, any obligation under, or give rise to a right by any Third Party to terminate or amend its obligations under, any Purchased
Contract, or result in the creation of any Encumbrance (other than Permitted Encumbrances) upon any of the Assets, which violation,
breach, default or Encumbrance would have a Material Adverse Effect. For the avoidance of doubt, there are no Purchased Contracts
which provide any party thereto with the right to cancel or terminate their Purchased Contract in the event of (i) an assignment
of the Purchased Contract to the Buyer, or (ii) the sale of substantially all of the D-Vasive’s assets to the Buyer;

 

(c)to
Sellers’ Knowledge, violate any applicable Law of any Governmental Body having jurisdiction over Sellers or the Assets,
which would have a Material Adverse Effect; or

 

(d)except
as set forth on Schedule 4.3(d) hereto, require the consent, authorization, order or approval of, filing or registration
with, or waiver of any right of first refusal or first offer from, any Governmental Body or any Third Party, that has not been
obtained, except as would not individually or in the aggregate be materially adverse to Sellers (any such consents, approvals,
orders, authorizations, registrations, declarations and filings listed on Schedule 4.3(d) being referred to herein collectively
as the “D-Vasive Consents”).

 

4.4.Assets
– Sufficiency and Title.

 

(a)The
Assets constitute all of the assets, tangible and intangible, of any nature whatsoever, necessary to operate the Business in the
manner presently operated by Sellers.

 

(b)D-Vasive
has good and valid title to, or a valid leasehold interest or license in, all of the Assets, free and clear of any Encumbrances
except for Permitted Encumbrances, and has the full right to sell, convey, transfer, assign and deliver all of the Assets to Buyer
at the Closing, free and clear of all Encumbrances except for Permitted Encumbrances.

 

(c)Except
as set forth on Schedule 4.4(c) hereto and subject to normal wear and tear, all the tangible Assets are in good working
condition and repair, consistent with their current use in the Business.

 

(d)There
are no material defects in, or conditions with, the Assets that will negatively impact Buyer’s ability to use the Assets
as they are currently used. D-Vasive is not a party to any Contract with any Third Party to sell, transfer, assign, convey or
otherwise dispose of any portion of the Assets or any portion of D-Vasive’s interest in the Assets.

 

4.5.Licenses
and Permits. Except as set forth on Schedule 4.5, to Sellers’ Knowledge, D-Vasive is in compliance with the Licenses
and Permits, if any, required for it to own, operate, lease or license the Assets as such Assets are currently owned, operated,
leased or licensed, and to operate the Business as such Business is currently operated, and to Sellers’ Knowledge, no Action
is pending or threatened which could revoke or limit any License or Permit.

 

    	 	 

    	 

    

 

4.6.Compliance
with Laws; Litigation. To Sellers’ Knowledge, D-Vasive is in compliance with all Laws of or from Governmental Bodies
applicable to the Business and the Assets.

 

(a)Except
as set forth on Schedule 4.6, there are no Actions pending or, to Sellers’ Knowledge, threatened, against D-Vasive
or any of its officers, managers, employees or members in their capacity as such, with respect to the Business, the Assets or
the Purchased Contracts. D-Vasive is not subject to any order (consent or other), judgment, decree, injunction or stipulation
of or with any court or other Governmental Body that names D-Vasive and imposes a material ongoing obligation with respect to
the operation of the Business and the Assets, which would have a Material Adverse Effect.

 

(b)There
are no Actions pending or, to Sellers’ Knowledge, threatened by or against Sellers with respect to this Agreement or any
of the Collateral Agreements, or in connection with the transactions contemplated hereby or thereby, that would reasonably be
expected to prevent or materially delay the consummation by Sellers of the transactions contemplated hereby or thereby or would
reasonably be expected individually or in the aggregate to have a Material Adverse Effect.

 

4.7.Purchased
Contracts. All amounts due and payable with respect to the Purchased Contracts prior to the date hereof have been paid through
the date hereof and all such amounts due and payable immediately prior to the Closing Date will have been paid through the Closing
Date and, to Sellers’ Knowledge, there are no material breaches, violations or defaults under any provision of any Purchased
Contracts, which would have a Material Adverse Effect. To Sellers’ Knowledge, D-Vasive has complied with all terms of use,
terms of service and other obligations of the Purchased Contracts and all associated policies and guidelines relating to its use
of any social media platforms, sites or services in the conduct of the Business.

 

4.8.Taxes.
Except as set forth on Schedule 4.8:

 

(a)To
the Sellers’ knowledge, there are no liens for Taxes upon any of the Assets, except for liens for Taxes not yet due and
payable.

 

(b)D-Vasive
has paid, or made provision for the payment of, all material Taxes required to be paid by it with respect to the Business and
the Assets.

 

4.9.Brokers.
No broker, finder, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s
or other similar fee or commission from any Party in connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of Sellers or any of its Affiliates.

 

4.10.Environmental
Matters.

 

(a)To
Sellers’ Knowledge, Sellers are operating the Business and Assets in material compliance with all applicable Environmental
Laws;

 

(b)D-Vasive
has not, and, to Sellers’ Knowledge, no other Person has, used, stored, disposed of, released or managed (whether by act
or omission) any Hazardous Substances in a manner that could reasonably be expected to result in the owner or operator of the
Business or Assets incurring any material liability or expense;

 

    	 	 

    	 

    

 

(c)D-Vasive
has not received any written notice from any Governmental Body that D-Vasive is in violation of any Environmental Law in connection
with its operation of the Business and Assets; and

 

(d)D-Vasive
is not subject to any pending or, to Sellers’ Knowledge, threatened Action in connection with the Business or Assets involving
a demand for damages, injunctive relief, penalties or other potential liability with respect to a violation of any Environmental
Law or release of any Hazardous Substance.

 

4.11.Investment
Representations.

 

(a)D-Vasive
(or its designees) are acquiring the shares of Common Stock comprising the Purchase Price for its own account and not with a view
to the distribution thereof in contravention of the Securities Act of 1933, as amended (the “Securities Act”).

 

(b)In
proceeding with the transactions contemplated hereby, D-Vasive (and its designees) are not relying upon any representation or
warranty of Buyer or Parent, or any of its officers, directors, employees, agents or representatives thereof, except the representations
and warranties set forth herein and the statements contained in Parent’s filings with the Securities and Exchange Commission.

 

(c)D-Vasive
and its designees have such knowledge and experience in financial and business matters as to be capable of evaluating the merits
and risks of acquiring the shares of Common Stock comprising the Purchase Price and understand the risks of, and other considerations
relating to, its acquisition of the shares of Common Stock.

 

4.12
Proprietary Rights.

 

(a)Registered
IP. Schedule 4.12(a) contains a complete and accurate list of all Registered IP owned or purported to be owned by or
filed in the name of D-Vasive, which list identifies (i) the jurisdiction in which each item of Registered IP has been registered
or filed, and (ii) any item of Registered IP that is jointly owned with any other Person.

 

(b)All
Registered IP are active and have not been abandoned for any reason.

 

(c)
All required filings and fees (“Registered IP Fees”) related to the Registered IP have been timely filed with
and paid to the relevant Governmental Bodies and authorized registrars, and all Registered IP are in good standing. D-Vasive has
provided Buyer with true and complete copies of all file histories, documents, certificates, Government Body actions, correspondence
and other materials related to all Registered IP.

 

(d)
Third Party IP and Inbound Licenses. Schedule 4.12(d) contains a complete and accurate list of all Intellectual
Property licensed to D-Vasive (other than non-customized, executable code, internal use software licenses for software that is
not incorporated into, or used directly in the development, manufacturing, or distribution of, D-Vasive’s products or services
and that is generally available on standard terms for less than $2,000), and the corresponding Contracts in which such Intellectual
Property is licensed to D-Vasive.

 

    	 	 

    	 

    

 

(e)Outbound
Licenses. Schedule 4.12(e) contains a complete and accurate list of all Contracts currently in effect in which any
Person has been granted any license under, or otherwise transferred or conveyed any right or interest in, D-Vasive Intellectual
Property; provided, however, that all consumers who have downloaded any apps created and/or distributed by D-Vasive are not listed
in such Schedule (it being recognized that such consumers have a license to use such apps). D-Vasive is not bound by, or subject
to, any Contract containing any covenant or other provision that in any way limits or restricts the ability of D-Vasive to use,
exploit, assert, or enforce the D-Vasive Intellectual Property anywhere in the world which limitations or restrictions would reasonably
be expected to have a Material Adverse Effect (it being understood that D-Vasive’s apps may be distributed through third
party apps markets and that such distributors may impose various restrictions on distribution under the applicable agreements
for distributing apps through such channels).

 

(f)Demand
Letters. Schedule 4.12(f) contains a complete and accurate list (and D-Vasive has provided true, complete and accurate
copies to Buyer) of all letters and other written or electronic communications or correspondence, between D-Vasive and any other
Person regarding any actual, alleged, claimed, or suspected infringement or misappropriation of D-Vasive Intellectual Property,
along with a brief description of the current status of each such matter (“Demand Letters”).

 

(g)Ownership
Free and Clear. D-Vasive exclusively owns all right, title, and interest to and in the D-Vasive Intellectual Property (other
than Intellectual Property licensed from Third Parties) free and clear of any Encumbrances other than Encumbrances in favor of
Buyer.

 

(h)Valid
and Enforceable. All D-Vasive Intellectual Property is valid, subsisting, and enforceable (although D-Vasive makes no representations
with regard to Intellectual Property licensed from Third Parties). Without limiting the generality of the foregoing, if applicable,:

 

(i)
Each U.S. patent application and U.S. patent owned by D-Vasive was filed within one year of a printed publication, public use,
or offer for sale of each invention described in the U.S. patent application or U.S. patent. Each foreign patent application and
foreign patent owned by D-Vasive was filed or claims priority to a patent application filed prior to each invention described
in the foreign patent application or foreign patent being made available to the public. No trademark or trade name owned, used,
or applied for by D-Vasive conflicts or interferes with any trademark or trade name owned, used, or applied for by any other Person.
D-Vasive has no Knowledge with respect to and is not aware of any other basis for a claim that any of the D-Vasive Intellectual
Property is invalid or unenforceable.

 

(ii)All
D-Vasive Intellectual Property (other than in-licensed Intellectual Property) that is Registered IP is in compliance with all
formal legal requirements and all filings, payments, and other actions required to be made or taken to maintain such Registered
IP in full force and effect have been made by the applicable deadline. Schedule 4.12(h)(ii) contains a complete and accurate
list of all actions, filings, and payments that must be taken or made through December 31, 2015, in order to maintain such Registered
IP in full force and effect.

 

(iii)No
legal proceeding (including any interference, opposition, reissue, or reexamination proceeding) is pending or, to Sellers’
Knowledge, threatened, in which the scope, validity, or enforceability of any D-Vasive Intellectual Property is being, has been,
or could reasonably be expected to be contested or challenged, and there has been no such legal proceeding.

 

(i)Trade
Secrets. D-Vasive has taken all reasonable steps to maintain the confidentiality of and otherwise protect and enforce its
respective rights in its respective Trade Secrets.

 

    	 	 

    	 

    

 

(j)
Employees and Contractors. All employees and contractors of D-Vasive who were involved in the creation or development of
D-Vasive Intellectual Property will sign agreements assigning such D-Vasive Intellectual Property to D-Vasive and binding them
to confidentiality provisions regarding to D-Vasive Intellectual Property. No past or present member, officer, manager, or employee
of D-Vasive have any claim, right, or interest to or in any D-Vasive Intellectual Property. Notwithstanding the foregoing, employees
and contractors who contributed to development of the D-Vasive Intellectual Property using their own, pre-existing Intellectual
Property (listed on Schedule 4.12(j), the “Contributing IP”), shall maintain full rights and ownership to such
Contributing IP; provided, however, that the owners of the Contributing IP agree to enter into license agreements with Buyer with
respect to Buyer’s license of the Contributing IP.

 

(k)Chain
of Title. D-Vasive has properly recorded assignments from all named inventors for all patents and patent applications included
in the Registered IP owned or purported to be owned by D-Vasive.

 

(l)Impairment
of Goodwill. The goodwill associated with or inherent in D-Vasive’s trademarks (both registered and unregistered) has
not been impaired.

 

(m)Infringement
of Sellers Intellectual Property by Third Parties. To Sellers’ Knowledge, no Person has infringed, misappropriated,
or otherwise violated, and no Person is currently infringing, misappropriating, or otherwise violating, any D-Vasive Intellectual
Property, provided D-Vasive makes no representation with regard to in-licensed Intellectual Property.

 

(n)Government
Rights. No government funding or personnel were used, directly or indirectly, by Sellers to develop or create, in whole or
in part, any of D-Vasive Intellectual Property.

 

(o)Effects
of This Transaction. Neither the execution or delivery of this Agreement nor the performance of this Agreement and the consummation
of the transactions contemplated hereby will, with or without notice or lapse of time, result in, or give any other Person the
right or option to cause or declare, (i) a loss of, or Encumbrance or restriction on, any D-Vasive Intellectual Property or any
license to Intellectual Property held by D-Vasive; (ii) a breach of any license agreement listed or required to be listed in Schedule
4.12(d); (iii) the release or delivery of any D-Vasive Intellectual Property to any other Person; or (iv) the grant, assignment,
or transfer to any other Person of any license or other right or interest under, to, or in any of the D-Vasive Intellectual Property.

 

(p)No
Infringement of Third Party IP Rights. To Sellers’ Knowledge, D-Vasive has never infringed, misappropriated, or otherwise
violated the Intellectual Property Rights of any other Person, which infringement or misappropriation would reasonably be expected
to have a Material Adverse Effect. Without limiting the generality of the foregoing, to Sellers’ Knowledge no product, information,
or service ever manufactured, produced, distributed, published, used, provided, or sold by or on behalf of D-Vasive, and no Intellectual
Property ever owned, used, or developed by D-Vasive, has infringed, misappropriated, or otherwise violated the Intellectual Property
Rights of any other Person, which infringement or misappropriation would reasonably be expected to have a Material Adverse Effect.

 

(q)Pending,
Threatened, or Possible IP Infringement Claims. There are no pending or to Sellers’ Knowledge threatened infringement,
misappropriation, or similar claims or legal proceedings against D-Vasive or to Sellers’ knowledge against any other Person
who would be entitled to indemnification by D-Vasive for such claim or legal proceeding. D-Vasive has never received any written
notice of any actual, alleged, possible, potential, or suspected infringement or misappropriation of any other Person’s
Intellectual Property Rights by D-Vasive or by any product or service developed, manufactured, distributed, provided, or sold
by or on behalf of D-Vasive.

 

(r)Sufficiency.
To Sellers’ Knowledge, D-Vasive owns or otherwise has all Intellectual Property rights needed to conduct its business as
currently conducted.

 

    	 	 

    	 

    

 

4.13Privacy;
Data Security.

 

(a)
D-Vasive has not collected Personal Information, including data collected from an IP address, web beacon, pixel tag, ad tag, cookie,
JavaScript, local storage, Software, or by any other means, or from a particular computer, Web browser, mobile telephone, or other
device or application, where such data is or may be used to identify or contact an individual, device, or application (including,
without limitation, by means of an advertisement or content), or to predict or infer the preferences, interests, or other characteristics
of the device or of a user of such device or application or is otherwise used to target advertisements or other content to a device
or application or to a user of such device or application (“Non-Personal Information”). D-Vasive does not,
and the Assets purchase do not provide for collection or utilization of, Personal Information or Non-Personal Information, nor
perform in any manner when utilized by users as intended, any function that would collect Personal Information or Non-Personal
Information from users of its Assets. D-Vasive has complied in all material respects with all Laws (which for such purposes shall
include the policy of such third party apps markets that distribute D-Vasive’s apps) relating to: (i) the privacy of users
of (including Internet or mobile users who view or interact with) the D-Vasive Offerings and all of the websites of D-Vasive,
and (ii) the collection, use, storage, retention, disclosure, and disposal of any Personal Information or Non-Personal Information
collected by D-Vasive, or by Third Parties acting on the D-Vasive’s behalf or having authorized access to the D-Vasive’s
records. The privacy practices of D-Vasive concerning the collection, use, retention, disclosure, and disposal, of Personal Information
or Non-Personal Information conform, and at all times have materially conformed, to all of the contractual commitments of D-Vasive
including to viewers of the websites of the D-Vasive and users of (including Internet users who view or interact with) the D-Vasive
Offerings and the contractual commitments of D-Vasive through which D-Vasive Offerings are offered. D-Vasive Offerings conform,
and at all times have materially conformed to applicable Law and, to the extent subject thereto, to the Network Advertising Initiative’s
Self-Regulatory Code of Conduct (2008), the Digital Advertising Alliance’s Self-Regulatory Principles for Online Behavioral
Advertising, and the Federal Trade Commission’s Principles for the Self Regulation of Online Behavioral Advertising (2010).
Except as required to process a transaction or provide the D-Vasive Offerings, D-Vasive has not disclosed, and does not have any
obligation to disclose, any Personal Information or Non-Personal Information to any Third Party. D-Vasive and its websites and
the D-Vasive Offerings, have made all disclosures to users or customers and obtained all necessary consents from users or customers
required by applicable Law, and none of such disclosures made or contained in any of D-Vasive’s websites or in any such
materials have been inaccurate, misleading or deceptive or in violation of any applicable Law. No Actions have been asserted or,
to the knowledge of the Sellers, are threatened against D-Vasive by any Person alleging a violation of any Person’s privacy,
personal or confidentiality rights under the Privacy Policies or any applicable Law. Neither this Agreement nor the transactions
contemplated by this Agreement, including any disclosures of data, will violate the Privacy Policies as they currently exist or
as they existed at any time during which any of the Personal Information or Non-Personal Information was collected or obtained.

 

(b)To
the knowledge of the Sellers, at all times since inception, D-Vasive has complied in all material respects with any Law applicable
to D-Vasive relating to the security of Personal Information to which D-Vasive or Third Parties acting on D-Vasive’s behalf
or otherwise having authorized access to the D-Vasive’s records, have access or otherwise collect or handle. To the knowledge
of the Sellers, D-Vasive’s information security practices conform, and at all times have conformed, in all material respects
with (i) any information security statements made by D-Vasive and (ii) all of the contractual commitments of D-Vasive, including,
but not limited to, any contractual commitments to analytics providers, data providers, publishers, advertisers and advertising
networks, exchanges and advertising networks, through which D-Vasive Offerings are offered. D-Vasive has made no statements to
the general public regarding the information security practices of D-Vasive. No Actions have been asserted or, to the knowledge
of the Sellers, are threatened against D-Vasive by any Person with respect to the security of Personal Information. To the knowledge
of the Sellers, there has been no unauthorized access to or unauthorized disclosure or use of Personal Information owned or licensed
by D-Vasive or in D-Vasive’s possession or control by or to any Third Party, including any Governmental Entity.

 

    	 	 

    	 

    

 

4.14Pro
Forma Financial Statements Seller shall produce audited pro forma financial statements within such number days requested
by the Buyer within such a number of days mutually agreed by the Parties after execution of this Agreement. All expenses resulting
from the preparation and auditing of the financial statement related to the Business shall be paid by the Buyer. Sellers will
use their best efforts to assist with the preparation and audit of financial statement related to the Business as required by
applicable securities laws.

 

4.15Right
to Use “John McAfee” in Company’s Name. To the extent the Company desires to use “John McAfee”
in its company name, Seller shall ensure John McAfee shall authorize such use without any compensation and make sure such use
will not infringe any other party’s rights. Sellers shall indemnify, defend and hold harmless Buyer, Parent and their shareholders,
directors, officers, employees, Affiliates, agents, representatives and permitted assigns, from and against any and all liabilities,
losses, damages, costs and expenses (including reasonable attorney’s fees and costs) directly or indirectly, as a result
of, in connection with, or based upon or arising from the Company’s use of “John McAfee” in its company name.

 

ARTICLE
V

REPRESENTATIONS AND WARRANTIES OF BUYER AND PARENT

 

Except
as set forth in Schedules attached hereto, Buyer and Parent, jointly and severally, represent and warrant to Sellers that the
statements contained in this Article V are true and correct as of the date hereof.

 

5.1.Organization.
Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada. Parent is
a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada. Buyer and Parent have
all requisite corporate power and authority to own, lease or license and operate their business and assets as currently operated.

 

5.2.Authorization;
Binding Effect.

 

(a)Buyer
and Parent have all requisite corporate power and authority to execute and deliver this Agreement and each Collateral Agreement
to which they are or will be parties and to effect the transactions contemplated hereby and thereby. The execution, delivery and
performance by Buyer and Parent of this Agreement and each Collateral Agreement to which they are or will be parties and the consummation
by Buyer and Parent of the transactions contemplated hereby and thereby have been duly and validly approved by Buyer’s and
Parent’s boards of directors, and no other corporate actions or proceedings on the part of Buyer or Parent are necessary
to authorize the execution, delivery and performance by Buyer of this Agreement or the Collateral Agreements to which they are
or will be parties or the transactions contemplated hereby and thereby.

 

(b)Buyer
and Parent have duly and validly executed and delivered this Agreement. When this Agreement and each of the Collateral Agreements
to which Buyer and Parent are or will be a party have been duly executed and delivered by Buyer and Parent and (assuming due execution
by Sellers), this Agreement and each such Collateral Agreement to which they are parties will constitute valid and legally binding
obligations of Buyer and Parent, enforceable against them in accordance with their respective terms, except as such agreements
may be subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws and equitable
principles relating to or affecting or qualifying the rights of creditors generally and general principles of equity.

 

    	 	 

    	 

    

 

(c)As
of the date hereof, the authorized capital stock of Parent is 75,000,000 shares of Common Stock, par value $0.001 per share, of
which [18,200,000] (exclusive of the Purchase Price Shares) are issued and outstanding, and 1,500,000 shares of preferred stock,
par value $0.001 per share, of which [  ] are issued and outstanding. Except as otherwise disclosed herein or as disclosed in the
SEC Documents, (i) no shares of Parent’s capital stock are subject to preemptive rights or any other similar rights or any
liens or encumbrances suffered or permitted by Parent, (ii) there are no outstanding debt securities, (iii) there are no outstanding
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into or exchangeable for, any shares of capital stock of Parent or any of its subsidiaries, or contracts,
commitments, understandings or arrangements by which Parent or any of its subsidiaries is or may become bound to issue additional
shares of capital stock of Parent or any of its subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of Parent or any
of its subsidiaries, (iv) other than as disclosed in the SEC Documents, there are no agreements or arrangements under which Parent
or any of its subsidiaries is obligated to register the sale of any of their securities under the Securities Act, (v) there are
no outstanding securities or instruments of Parent or any of its subsidiaries which contain any redemption or similar provisions,
and there are no contracts, commitments, understandings or arrangements by which Parent or any of its subsidiaries is or may become
bound to redeem a security of Parent or any of its subsidiaries, (vi) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Purchase Price as described in this Agreement, as applicable,
and (vii) Parent does not have any restricted stock units, stock appreciation rights or “phantom stock” plans or agreements
or any similar plan or agreement. Parent has furnished to the Sellers (and its designees) true and correct copies of Parent’s
Certificate of Incorporation, as amended and as in effect on the date hereof (the “Certificate of Incorporation”),
and Parent’s Bylaws, as amended and as in effect on the date hereof (the “Bylaws”), and the SEC Documents
disclose summaries of the terms of all securities convertible into or exercisable for Common Stock, if any, and copies of any
documents containing the material rights of the holders thereof in respect thereto. The foregoing is subject to the following
issuances contemplated prior to Closing: (i) 5,400,000 shares of Common Stock issued with respect to the cash exercise of the
Company’s warrants at an exercise price of $0.25 per share; and (ii) 2,500,000 shares of Common Stock to be issued to directors,
officers and employees of Parent.

 

5.3.Non-Contravention;
Buyer’s Consents. The execution, delivery and performance of this Agreement and the Collateral Agreements by Buyer and
Parent, and the consummation of the transactions contemplated hereby and thereby do not and will not:

 

(a)conflict
with or result in a breach or violation of any provision of any organizational documents of Buyer or Parent,

 

(b)violate,
or result in a breach of, or constitute an occurrence of default under any provision of, result in the acceleration or cancellation
of any obligation under, or give rise to a right by any Third Party to terminate or amend its obligations under, any Contract
to which Buyer or Parent is a party or by which it or its assets or properties are bound, or result in the creation of any Encumbrance
upon any of its assets or properties, which violation, breach, default or Encumbrance would individually or in the aggregate be
material to Buyer or Parent or materially impair or delay or prevent the consummation of the transactions contemplated hereby,

 

    	 	 

    	 

    

 

(c)to
Knowledge of Buyer and Parent, violate any applicable Law of any Governmental Body having jurisdiction over Buyer, Parent or any
of their properties, which violation would individually or in the aggregate be materially adverse to Buyer or Parent, or

 

(d)except
as set forth on Schedule 5.3(d) hereto, require the consent, authorization, order or approval of, filing or registration
with, or waiver of any right of first refusal or first offer from, any Governmental Body or any Third Party, that has not been
obtained, except as would not individually or in the aggregate be materially adverse to Buyer or Parent (any such consents, approvals,
orders, authorizations, registrations, declarations and filings listed on Schedule 5.3(d) being referred to herein collectively
as the “Buyer’s Consents”).

 

5.4.Compliance
with Laws; Litigation.

 

(a)To
Knowledge, Buyer and Parent are in material compliance with all Laws of or from Governmental Bodies applicable to their business
and assets; and

 

(b)There
are no Actions pending against Buyer or Parent or, to the Knowledge of Buyer or Parent, threatened by or against Buyer or Parent
with respect to this Agreement or any of the Collateral Agreements, or in connection with the transactions contemplated hereby
or thereby.

 

5.5.SEC
Documents; Financial Statements. Parent has filed all reports, schedules, forms, statements and other documents required to
be filed by Parent under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
twelve (12) months preceding the date hereof (or such shorter period as Parent was required by law or regulation to file such
material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively
referred to herein as the “SEC Documents”) on a timely basis or has received a valid extension of such time
of filing and has filed any such SEC Documents prior to the expiration of any such extension. As of their respective dates, the
SEC Documents complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.
None of the SEC Documents, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading. The financial statements of Parent included in the SEC Documents comply in all material respects with
applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing.
Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied
on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP,
and fairly present in all material respects the financial position of Parent and its consolidated subsidiaries as of and for the
dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments. All non-GAAP financial information included in the SEC Documents complies with
the requirements of Regulation G and Item 10 of Regulation S-K regarding the use of non-GAAP financial information. Except as
set forth in the SEC Documents, Parent has received no notices or correspondence from the SEC for the one year preceding the date
hereof. The SEC has not commenced any enforcement proceedings against Parent or any of its subsidiaries.

 

5.6.Brokers.
No broker, finder, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s
or other similar fee or commission from any Party in connection with the transactions contemplated by this Agreement based on
arrangements made by or on behalf of Buyer, Parent or any Affiliate thereof.

 

    	 	 

    	 

    

 

5.7.Absence
of Certain Changes. Except as disclosed in the SEC Documents, since March 31, 2014, there has been no Material Adverse Effect.
Parent has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any bankruptcy
Law nor does Parent or any of its subsidiaries have any knowledge or reason to believe that its creditors intend to initiate involuntary
bankruptcy or insolvency proceedings.

 

5.8.Issuance
of Shares. Except for the restrictions set forth in the Lockup Agreement, all shares of Common Stock to be issued to D-Vasive
or its designees pursuant to this Agreement will, when issued pursuant to the terms of this Agreement, be duly authorized, validly
issued, fully paid and nonassessable and free of preemptive rights, and free and clear of all liens and encumbrances and free
of any restriction on transfer, other than restrictions on transfer under applicable federal and state securities laws.

 

5.9.Absence
of Litigation. Except as disclosed in the SEC Documents, there is no action, suit, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of Parent
or any of its subsidiaries, threatened against or affecting Parent, the Common Stock or any of Parent’s or its subsidiaries’
officers or directors in their capacities as such, which could reasonably be expected to have a Material Adverse Effect.

 

5.10.Tax
Status. Parent and each of its subsidiaries has made or filed all federal and state income and all other material tax returns,
reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that Parent and each
of its subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes)
and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due
on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provision
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the
officers of the Parent know of no basis for any such claim.

 

5.11.Cash
at Closing. There shall be $1,500,000 cash on hand on the consolidated balance sheet of the Parent at the Closing (prior to delivery
of the Closing Cash).

 

ARTICLE
VI

COVENANTS

 

6.1.Access
to Information.

 

(a)For
a period of three (3) years after the Closing Date, upon reasonable prior written notice, the Parties shall furnish or cause to
be furnished to each other and their employees, agents, auditors and representatives access, during normal business hours, to
such information, books and records relating to the Business and the Assets as is reasonably necessary for financial reporting
and accounting matters, the preparation and filing of Tax Returns, reports or forms for the defense of any Tax claims, assessments,
audits or disputes, or the prosecution or defense of any Action and shall cooperate with each other to the extent reasonably requested
for the preparation of such financial reporting, accounting and Tax matters, provided, that with respect to any Tax Returns
or other records relating to Tax matters or any other Action, a Party shall have reasonable access to such information until the
applicable statute of limitations, if any, shall have expired, and provided, further, that in either case such access
shall be subject to reasonable and customary restrictions with respect to confidentiality. Each Party shall have the right to
copy any of such records at its own expense. No Party shall be required by this Section 6.1(a) to take any action that would unreasonably
interfere with the conduct of its business or unreasonably disrupt its normal operations. Further, the Parties understand that
it is the intention of D-Vasive to terminate all operations following closing and to liquidate its assets to its shareholders
and as required, to creditors, prior to the three (3) year term reflected above.

 

    	 	 

    	 

    

 

(b)Sellers
and Buyer each agree to preserve, for at least three (3) years after the Closing Date, all material books, ledgers and other records
that are (i) reasonably related to the Business or Assets and (ii) in their possession; provided, that each Party will
preserve all such material books, ledgers and other records relating to Tax matters until expiration of the applicable statute
of limitations. Notwithstanding the foregoing, Buyer and Parent understand that it is the intention of Sellers to terminate all
operations following closing and to liquidate its assets to its members and as required, to creditors, prior to the three (3)
year term reflected above.

 

(c)On
and after the Closing Date, Sellers and Buyer will take all appropriate action and execute all documents, instruments or conveyances
of any kind which may be reasonably necessary or advisable to carry out the intent and purposes of this Agreement and the Collateral
Agreements, including putting Buyer in possession and operating control of the Business and the Assets.

 

6.2.Confidentiality.

 

(a)After
the Closing Date, Sellers will not, and Sellers will use reasonable commercial efforts to cause its Affiliates not to, use for
its or their own benefit or divulge or convey to any Third Party, any Buyer or Parent Confidential Information relating to the
Business or the Assets.

 

(b)After
the Closing Date, Buyer and Parent will not, and Buyer and Parent will use reasonably commercial efforts to cause its Affiliates
not to, use for its or their own benefit or divulge or convey to any Third Party, any Sellers Confidential Information.

 

(c)Notwithstanding
the foregoing, neither Sellers nor Buyer or Parent shall be deemed to have violated this Section 6.3 if it or any of its Affiliates
receives a request to disclose all or any part of the Buyer or Parent Confidential Information or Sellers Confidential Information,
as applicable, in a legal proceeding or under the terms of a subpoena, civil investigative demand or order issued by a Governmental
Body, and it or such Affiliate, to the extent not inconsistent with such request and to the extent time reasonably allows: (i)
notifies the other party of the existence, terms and circumstances surrounding such request; and (ii) furnishes only such portion
of the Buyer or Parent Confidential Information or Sellers Confidential Information, as applicable, which it is advised by its
counsel is legally obligated to be disclosed and exercises reasonable efforts to obtain an order or other reliable assurance that
confidential treatment will be accorded to the disclosed Buyer Confidential Information or Sellers Confidential Information, as
applicable.

 

(d)For
purposes of this Agreement, “Sellers Confidential Information” consists of all information, knowledge or data
that is not related solely to the Business, Assets or the Purchased Contracts and that is not in the public domain or otherwise
publicly available which are treated as confidential by Sellers as of the date hereof, provided, that Sellers Confidential Information
shall not include information that: (i) enters the public domain or becomes publicly available, so long as neither Buyer nor any
of its Affiliates, directly or indirectly, improperly causes such information to enter the public domain, (ii) after the date
of this Agreement becomes known to Buyer or any of its Affiliates on a non-confidential basis from a source that is not prohibited
from disclosing such information to Buyer or such Affiliate by a contractual or other legal duty owed to Sellers, or (iii) after
the date of this Agreement is developed independently by Buyer or any Affiliate of Buyer without violation of this Agreement.

 

    	 	 

    	 

    

 

(e)For
purposes of this Agreement, “Buyer Confidential Information” consists of all information, knowledge or data
related to the Buyer and/or Parent or its business not in the public domain or otherwise publicly available which are treated
as confidential by Buyer or Parent as of the date hereof, provided that Buyer Confidential Information shall not include information
that: (i) enters the public domain or becomes publicly available, so long as neither Sellers nor any of its Affiliates, directly
or indirectly, improperly causes such information to enter the public domain, (ii) after the date of this Agreement becomes known
to Sellers or any of its Affiliates on a non-confidential basis from a source that is not prohibited from disclosing such information
to Sellers or such Affiliate by a contractual or other legal duty owed to Buyer, or (iii) after the date of this Agreement is
developed independently by Sellers or any Affiliate of Sellers without violation of this Agreement.

 

(f)The
Buyer or Parent and the Sellers shall not issue any press release nor otherwise make any public statement regarding the transactions
contemplated hereby without the prior written consent of the other party, except as required by law or regulation or as otherwise
determined by a Party and its counsel. Notwithstanding the foregoing, Buyer and Parent shall have the right to issue press releases
and publicly reference the acquisition of Sellers upon Closing.

 

6.3.Payment
of Liabilities. Buyer and Parent agree and acknowledge that the Purchase Price to be paid pursuant to the Escrow Agreement
is intended to compensate D-Vasive for the satisfaction of various liabilities and obligations of D-Vasive, whether existing at
Closing or arising thereafter. To that end, D-Vasive agrees and acknowledges that the Escrow Shares shall be available to secure
any claims that may arise with respect to the Sellers’ representations, warranties, indemnification obligations or covenants,
including the covenants set forth in this Section 6.3, pursuant to this Agreement.

 

6.4.Noncompetition.
Except for any work done for and on behalf of Wyoming Tech, or any customers or affiliates of Wyoming Tech, for a period of eighteen
months (18) after the Closing Date, D-Vasive and Professor Eric N. Johnson shall not, and for a period of six months (6) after
the Closing Date, Henrik B. Christophersen, R. Wayne Pickell and D-Vasive shall not, directly or indirectly, invest in, own, manage,
operate, finance, control, advise, render services to or guarantee the obligations of any Person engaged in or planning to become
engaged in the commercial use or commercial development of the Assets, or any enhancements thereon, as intended to be used by
the Buyer, Parent or any of Parent’s subsidiaries for tethered UAVs. For the avoidance of doubt, the restrictions set forth
in the Section 6.4 shall not apply to the commercial use or commercial development of Contributing IP.

 

6.5.Cooperation.
After the Closing, and continuing for one (1) year from the Closing Date, to the extent it remains in existence, Sellers will
cooperate with Buyer in its efforts to continue and maintain for the benefit of Buyer those business relationships of Sellers
existing prior to the Closing and relating to the Business to be operated by Buyer after the Closing, including relationships
with lessors, employees, regulatory authorities, licensors, customers, suppliers and others, which reasonably requested cooperation
shall include, without limitation, assisting the Buyer from time to time with technical and engineering matter associated with
updating and maintaining the applications forming the core part of the Business. Sellers will refer to Buyer all inquiries relating
to such Business. Neither the Sellers nor the members of the Sellers shall take any action that would tend to diminish the value
of the Assets after the Closing or that would interfere with the Business of Buyer to be engaged in after the Closing.

 

    	 	 

    	 

    

 

ARTICLE
VII

SURVIVAL AND INDEMNIFICATION

 

7.1.Survival
of Representations and Warranties. The representations and warranties of Buyer, Parent and Sellers contained in this Agreement
or in any other certificate, writing or agreement delivered pursuant hereto or in connection herewith shall the survive the Closing
Date for one (1) year, except (i) as to any matter as to which a good faith claim has been submitted in writing to the other Party
describing the claim in reasonable detail before such date and identified as a claim for indemnification pursuant to this Article
VII, (ii) as to any matter which is based successfully upon fraud with respect to which the cause of action shall expire only
upon expiration of the applicable statute of limitations, and (iii) those representations and warranties set forth in Section
4.4(b) (title to the Assets), which shall survive for the applicable statute of limitations period, and Sections 4.8 (Taxes),
and 4.10 (Environmental Matters), and 4.15 (Proprietary Rights), which shall survive until the expiration of the applicable statute
of limitations.

 

7.2.Obligations
of Sellers. Subject to the other terms and conditions of this Article VII, Sellers shall indemnify, defend and hold harmless
Buyer and Parent and its shareholders, directors, officers, employees, Affiliates, agents, representatives and permitted assigns,
from and against any and all liabilities, losses, damages, costs and expenses (including reasonable attorney’s fees and
costs) (collectively, “Losses”), directly or indirectly, as a result of, in connection with, or based upon
or arising from any of the following: (i) any inaccuracy in or breach or non performance of any of the representations, warranties,
covenants or agreements made by Sellers in this Agreement or any Collateral Agreement; (ii) the failure of Sellers to perform
fully any covenant, provision or agreement to be performed or observed by it pursuant to this Agreement or any Collateral Agreement;
(iii) any other matter as to which Sellers in other provisions of this Agreement or any Collateral Agreement has agreed to indemnify
Buyer; (iv) any product, information, or service ever manufactured, produced, distributed, published, used, provided, or sold
by or on behalf of D-Vasive; (v) any Intellectual Property ever owned, used, or developed by D-Vasive that infringed, misappropriated,
or otherwise violated the intellectual property rights of any other Person; or (vi) any Excluded Liability.

 

7.3.Obligations
of Buyer/Parent. Subject to the other terms and conditions of this Article VII, Buyer and Parent shall indemnify, defend and
hold harmless Sellers and its members, managers, officers, employees, Affiliates, agents, representatives and permitted assigns
from and against any and all Losses, directly or indirectly, as a result of, in connection with, or based upon or arising from
any of the following: (i) any inaccuracy in or breach or non performance of any of the representations, warranties, covenants
or agreements made by Buyer or Parent in or pursuant to this Agreement or any Collateral Agreement; (ii) the failure of Buyer
or Parent to perform fully any covenant, provision or agreement to be performed or observed by it pursuant to this Agreement or
any Collateral Agreement; (iii) any other matter as to which Buyer in other provisions of this Agreement has agreed to indemnify
Sellers; or (iv) any Assumed Liability.

 

7.4.Notice
of Loss. The Indemnified Party with respect to any Loss shall give prompt notice thereof to the Indemnifying Party.

 

    	 	 

    	 

    

 

7.5.Defense.
In the event any Third Party shall make a demand or claim or file or threaten to file or continue any lawsuit, which demand, claim
or lawsuit may result in liability to an Indemnified Party in respect of matters covered by the indemnity under this Agreement,
or in the event that a potential Loss, damage or expense comes to the attention of any Party in respect of matters embraced by
the indemnity under this Agreement, then the Party receiving notice or becoming aware of such event shall promptly notify the
other Party in writing of the demand, claim or lawsuit. Within thirty (30) days after written notice by the Indemnified Party
(the “Notice”) to an Indemnifying Party of such demand, claim or lawsuit, except as provided in the next sentence,
the Indemnifying Party shall have the option, at its sole cost and expense, to retain counsel to defend any such demand, claim
or lawsuit; provided that counsel who will conduct the defense of such demand, claim or lawsuit will be approved by the Indemnified
Party whose approval will not unreasonably be withheld. The Indemnified Party shall have the right, at its own expense, to participate
in the defense of any suit, action or proceeding brought against it with respect to which indemnification may be sought hereunder;
provided, if (i) the named parties to any such proceeding (including any impleaded parties) include both the Indemnifying
Party and the Indemnified Party, representation of both parties by the same counsel would be inappropriate due to actual or potential
differing interests between them, and the Indemnifying Party has not retained separate counsel for the Indemnified Party, (ii)
the employment of counsel by such Indemnified Party has been authorized in writing by the Indemnifying Party, or (iii) the Indemnifying
Party has not in fact employed counsel to assume the defense of such action within a reasonable time; then, the Indemnified Party
shall have the right to retain its own counsel at the sole cost and expense of the Indemnifying Party, which costs and expenses
shall be paid by the Indemnifying Party on a current basis. No Indemnifying Party, in the defense of any such demand, claim or
lawsuit, will consent to entry of any judgment or enter into any settlement without the prior written consent of the Indemnified
Party. If any Indemnified Party will have been advised by counsel chosen by it that there may be one or more legal defenses available
to such Indemnified Party which are different from or in addition to those which have been asserted by the Indemnifying Party
and counsel retained by the Indemnifying Party declines to assert those defenses, then, at the election of the Indemnified Party,
the Indemnifying Party will not have the right to continue the defense of such demand, claim or lawsuit on behalf of such Indemnified
Party and will reimburse such Indemnified Party and any Person controlling such Indemnified Party on a current basis for the reasonable
fees and expenses of any counsel retained by the Indemnified Party to undertake the defense. In the event that the Indemnifying
Party shall fail to respond within thirty (30) days after receipt of the Notice, the Indemnified Party may retain counsel and
conduct the defense of such demand, claim or lawsuit, as it may in its sole discretion deem proper, at the sole cost and expense
of the Indemnifying Party, which costs and expenses shall be paid by the Indemnifying Party on a current basis. Failure to provide
Notice shall not limit the rights of such party to indemnification, except to the extent the Indemnifying Party’s defense
of the action is actually prejudiced by such failure. The assumption of the defense, or the non-assumption of the defense, by
the purported Indemnifying Party will not affect such party’s right to dispute its obligation to provide indemnification
hereunder.

 

7.6.Notice
by the Parties. Each Party agrees to promptly notify the other of any liabilities, claims or misrepresentations, breaches
or other matters covered by this Article VII upon discovery or receipt of notice thereof.

 

7.7.Limitations.
Except in the case of Losses arising from a Seller’s fraud or willful and intentional breach, the indemnification provided
hereunder by the Sellers shall be limited to the Purchase Price. Furthermore, each Indemnified Party entitled to indemnification
hereunder shall take all reasonable steps to mitigate all losses, costs, expenses and damages after becoming aware of any event
which could reasonably be expected to give rise to any Losses that are indemnifiable or recoverable hereunder.

 

EXCEPT
FOR LOSSES ARISING FROM A PARTY’S FRAUD OR WILLFUL AND INTENTIONAL BREACH, IN NO EVENT SHALL ANY PARTY TO THIS AGREEMENT
BE LIABLE UNDER ANY THEORY OF TORT, CONTRACT, STRICT LIABILITY OR OTHER LEGAL OR EQUITABLE THEORY FOR ANY CONSEQUENTIAL, EXEMPLARY,
PUNITIVE, SPECIAL, INCIDENTAL OR INDIRECT DAMAGES CLAIMED BY ONE OR MORE PARTIES HERETO AGAINST ANOTHER PARTY HERETO, EACH OF
WHICH IS HEREBY EXCLUDED BY AGREEMENT OF THE PARTIES REGARDLESS OF WHETHER SUCH DAMAGES WERE FORESEEABLE OR SUCH PARTY HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

 

7.8.Insurance
Benefits; Tax Proceeds. The amount of Losses recoverable by any Indemnified Party under this Agreement with respect to an
indemnity claim shall be reduced by (a) the amount of any payment actually received by or on behalf of any Indemnified Party from
any insurance policy net of any deductibles or other reasonable amounts payable with respect thereto, and (b) the amount of any
net Tax benefits available to any Indemnified Party from the incurrence or payment of such Losses.

 

    	 	 

    	 

    

 

7.9.Exclusive
Remedy. The indemnification rights provided in this Article VII shall be the sole and exclusive remedy available to the Parties
(including Indemnified Parties other than Buyer or Sellers) for any Losses related to an inaccuracy in or breach or nonperformance
of any of the terms, conditions, covenants, agreements, representations or warranties contained herein or in any of the other
Collateral Agreements or any right, claim or action arising from the transactions contemplated hereunder or thereunder, and each
Party hereby waives, to the fullest extent permitted by applicable Laws, any other rights or remedies that may arise under any
applicable Laws.

 

7.10.Survival.
This Article VII shall survive the Closing. The obligations set forth in Sections 7.2 and 7.3 shall remain in effect
until the later of the one (1) year anniversary of the Closing or any applicable statute of limitations. Any matter as to which
a good faith claim has been asserted by notice to the other Party that is pending or unresolved at the end of any applicable limitation
period set forth in Section 7.1 shall continue to be covered by this Article VII until such matter is finally terminated or otherwise
resolved by the Parties or by a court of competent jurisdiction and any amounts payable hereunder are finally determined and paid.

 

ARTICLE
VIII

MISCELLANEOUS PROVISIONS

 

8.1.Notices.
Except as otherwise provided herein or in a Collateral Agreement, all notices and other communications hereunder and under the
Collateral Agreements shall be in writing and shall be deemed to have been duly given upon receipt if (i) mailed by certified
or registered mail, return receipt requested, (ii) sent by a nationally recognized overnight delivery service (receipt requested),
fee prepaid, (iii) sent via facsimile with receipt confirmed, or (iv) delivered personally, addressed as follows or to such other
address or addresses of which the respective party shall have notified the other.

 

(a)If
to Sellers, to:

 

D-Vasive,
Inc.

126
Howard Ave.

Hope RI 02831

Contact@dvasive.com 

 

With
a copy (which shall not constitute notice) to:

 

Laxague
Law, Inc.

1
East Liberty, Suite 600

Reno,
NV 89501

Fax:
(775) 996-3283

Attention:
Joe Laxague, Esq,

 

(b)If
to Buyer or Parent, to:

 

MGT
Capital Investments, Inc.

500
Mamaroneck Avenue – Suite 204

Harrison,
NY 10528

Attention:
Robert B. Ladd, President and CEO

Fax:
(914) 630-7532

 

    	 	 

    	 

    

 

With
a copy (which shall not constitute notice) to:

 

Sichenzia
Ross Friedman Ference LLP

61
Broadway, 32nd Floor

New
York, New York 10006

Fax:
(212) 930-9725

Attention:
Jay M. Kaplowitz, Esq.

 

8.2.Expenses.
Except as otherwise provided in this Agreement or the Collateral Agreements, each Party will pay its own costs and expenses, including
legal and accounting expenses, related to the transactions contemplated by this Agreement and the Collateral Agreements, irrespective
of when incurred.

 

8.3.Entire
Agreement. The agreements of the Parties, which is comprised of this Agreement, the Schedules and Exhibits hereto and the
documents referred to herein, including the Collateral Agreements, sets forth the entire agreement and understanding between the
Parties and supersedes any prior agreement or understanding, written or oral, relating to the subject matter of this Agreement
and the Collateral Agreements.

 

8.4.Waiver
of Jury Trial. The Parties irrevocably waives the right to a jury trial in connection with any legal proceeding relating to
this Agreement or any of the Collateral Agreements or the enforcement of any provision hereof or thereof.

 

8.5.Governing
Law; Arbitration; Prevailing Party. This Agreement and the Collateral Agreements, and all claims or causes of action that
may be based upon, arise out of or relate to this Agreement or the Collateral Agreements will be construed in accordance with
and governed by the internal laws of the State of New York applicable to agreements made and to be performed entirely within such
State without regard to conflicts of laws principles thereof. Any dispute arising under or in connection with any matter of any
nature (whether sounding in contract or tort) relating to or arising out of this Agreement, shall be resolved exclusively by arbitration.
The arbitration shall be in conformity with and subject to the applicable rules and procedures of JAMS. The arbitration shall
be conducted before a panel of three (3) arbitrators, with one arbitrator to be selected by each of Sellers and Buyer and the
third arbitrator to be selected by the arbitrators selected by the Parties. The Parties agree to be (a) subject to the exclusive
jurisdiction and venue of the arbitration in New York, New York (b) bound by the decision of the arbitrator as the final decision
with respect to the dispute, and (c) subject to the jurisdiction of both of the federal courts of the United States of America
or the courts of the State, City and County of New York for the purpose of confirmation and enforcement of any award. The prevailing
party in any arbitration shall be entitled to recover its costs and expenses (including attorney’s fees and expenses) from
the non-prevailing party.

 

8.6.Waiver.
The rights and remedies of the Parties to this Agreement and the Collateral Agreements are cumulative and not alternative. Neither
the failure nor any delay by any party in exercising any right, power or privilege under this Agreement or the documents referred
to in this Agreement will operate as a waiver of such right, power or privilege, and no single or partial exercise of any such
right, power or privilege will preclude any other or further exercise of such right, power or privilege or the exercise of any
other right, power or privilege. To the maximum extent permitted by Law, (a) no claim or right arising out of this Agreement or
the Collateral Agreements can be discharged by one party, in whole or in part, by a waiver or renunciation of the claim or right
unless in writing signed by the other party; (b) no waiver that may be given by a party will be applicable except in the specific
instance for which it is given and will not operate as a waiver of, or estoppel with respect to, any subsequent or other failure
or noncompliance; and (c) no notice to or demand on one party will be deemed to be a waiver of any obligation of such party or
of the right of the party giving such notice or demand to take further action without notice or demand as provided in this Agreement
or the Collateral Agreements.

 

    	 	 

    	 

    

 

8.7.No
Oral Modification. Neither this Agreement nor any Collateral Agreement may be amended except by a written agreement executed
by the Parties. Any attempted amendment in violation of this Section 9.7 will be void ab initio.

 

8.8.Assignments;
Successors. No party may assign any of its rights under this Agreement or any Collateral Agreements without the prior written
consent of the other parties hereto or thereto. Subject to the preceding sentence, this Agreement and the Collateral Agreements
will apply to, be binding in all respects upon, and inure to the benefit of the successors and permitted assigns of the Parties.

 

8.9.Severability.
If any provision of this Agreement or the Collateral Agreements is held invalid or unenforceable by any court of competent jurisdiction,
the other provisions of this Agreement and the Collateral Agreements will remain in full force and effect; provided, that
the court making such determination shall have the power to and shall, subject to the discretion of such court, reduce the scope,
duration, area or applicability of such provision, to delete specific words or phrases, or to replace any invalid, void or unenforceable
provision with a provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or
unenforceable term or provision.

 

8.10.Limitations
on Public Disclosure. No Party may issue any press release, or make any public announcement or filing with a Governmental
Body, with respect to this Agreement or any Collateral Agreement without obtaining prior written consent of the other Party to
the issuance of such press release, or the making of such public announcement or filing, and to the contents thereof, which shall
not be unreasonably withheld or delayed; provided, that such Party may, without the prior consent of the other Party, issue
such press release, or make such public statement or filing, as may upon the advice of counsel be required by Law if it has provided
notice to and used reasonable efforts to consult with the other Party.

 

8.11.No
Third Party Beneficiaries. Nothing in this Agreement or the Collateral Agreements, express or implied, is intended to or shall
constitute the Parties as partners or as participants in a joint venture. This Agreement and the Collateral Agreements are solely
for the benefit of the Parties and, only to the extent provided in Article VII hereof, their respective Affiliates and employees,
representatives, agents, directors, officers, partners or principals, as applicable, or their respective assigns, for whom the
parties shall be entitled to enforce this Agreement, and no provision of this Agreement shall be deemed to confer upon any other
Third Parties any remedy, claim, liability, reimbursement, cause of action or other right; provided however, Parent and Buyer
understand and agree that D-Vasive’s designees shall have a right to receive the Common Shares constituting the Purchase
Price. Within 90 days of closing, D-Vasive shall provide Buyer and Parent with written notice of the intended recipients of the
shares of Common Stock and Parent shall use its best commercial efforts to honor such transfer request, including, without limitation,
notice and any opinions of counsel to Parent’s transfer agent for its Common Stock and Sellers shall have the right to enforce
such transfer request.

 

8.12.Incorporation
of Exhibit and Schedules. The Exhibits and Schedules identified and/or attached to this Agreement are incorporated herein
by reference and made a part hereof.

 

8.13.Counterparts.
This Agreement and the Collateral Agreements each may be executed simultaneously in two or more counterparts, each of which will
be deemed to be an original copy hereof or thereof and all of which together will be deemed, respectively, to constitute one and
the same agreement. Counterparts delivered by facsimile, e-mail or other electronic transmission shall be deemed to have the same
legal effect as delivery of an original signed copy of this Agreement.

 

    	 	 

    	 

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first written above.

 

	PARENT	 
	MGT Capital Investments, Inc.	 
	 	 	 
	By:	/s/
    Robert     B. Ladd	 
	Name:	Robert
    B. Ladd	 
	Title:
    	Chief
    Executive Officer and President	 

 

	BUYER	 
	MGT
    Cybersecurity, Inc.	 
	 	 	 
	By:	/s/
    Robert B. Ladd	 
	Name:	Robert
    B. Ladd	 
	Title:
    	SoleDirector	 

 

	SELLERS:	 
	 	 	 
	D-VASIVE, INC.	 
	 	 	 
	By:	/s/
    Louis Franco III	 
	 	Louis
    Franco III, President	 

 

	Shareholders
    of D-Vasive	 
	 	 
	/s/
    Louis Franco III	 
	Name:
    Louis Franco III	 
	 	 
	/s/
    John     Thomas Clore	 
	Name:
    John Thomas Clore	 

 

	Future Tense Secure Systems Inc.	 
	 	 	 
	 	 	 
	Name:	Tom
    Guscinski	 
	Title:
    	President	 

 

    	 	 

    	 

    

 

Annex
A

 

Allocation
of Purchase Price Shares

 

	 	 	Escrow Shares	 	 	Closing Shares	 
	Louis Franco III	 	 	0	 	 	 	1,500,000	 
	John Thomas Clore	 	 	0	 	 	 	1,500,000	 
	Future Tense Secure Systems Inc.	 	 	4,760,000	 	 	 	7,240,000	 
	Holders of D-Vasive, Inc. Convertible Notes	 	 	0	 	 	 	8,800,000	 
	Total	 	 	4,760,000	 	 	 	19,040,000	 

 

    	 	 

    	 

    

 

EXHIBIT
A

 

ESCROW
AGREEMENT

 

    	 	 

    	 

    

 

EXHIBIT
B

 

LOCKUP
AGREEMENT

 

    	 	 

    	 

    

 

EXHIBIT
C

 

BILL
OF SALE

 

    	 	 

    	 

    

 

EXHIBIT
D

 

IP
ASSIGNMENT

 

    	 	 

    	 

    

 

EXHIBIT
E

 

FORM
OF EMPLOYMENT AGREEMENT

 

    	 	 

    	 

    

 

EXHIBIT
F

 

FORM
OF CONSULTING AGREEMENTSManagement
Consulting Agreement

 

This
MANAGEMENT CONSULTING AGREEMENT (the “Agreement”) dated _________ [*], 2016 (the “Effective Date”), is
by and between MGT Capital Investments, Inc., a company incorporated under the laws of Delaware (the “Company”), and
Future Tense Secure Systems Inc. (the “Consultant”) with reference to the following facts:

 

WHEREAS,
Consultant provides consultation and advisory services relating to business management and product development to companies in
the Internet security and privacy industry, and

 

WHEREAS,
the Company desires to be assured of the services of the Consultant in order to avail itself to the Consultant’s experience,
skills, knowledge and abilities. The Company is therefore willing to engage the Consultant and the Consultant agrees to be engaged
upon the terms and conditions set forth herein.

 

NOW,
THEREFORE, in consideration of the foregoing, of the mutual promises and covenants set forth herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.Consulting
Services: As of the Effective Date, the Company hereby engages and Consultant hereby accepts the engagement to become a consultant
to the Company and to render such advice, consultation, information and services to the Company including (a) assistance with
executive management, (b) assistance with business and product development and with potential acquisitions or related transactions,
and (c) such other managerial assistance as the Company shall deem necessary or appropriate for its business.

 

2.Payment:
In consideration for the services to be rendered under this agreement, the Company hereby agrees to compensate Consultant as follows:

 

a.
Base Compensation. The Company shall pay the Consultant base compensation (the “Base Compensation”) at the
annual rate of $250,000 (U.S.) payable in equal installments to be made no less often than monthly. The Consultant’s Base
Compensation may be increased by the  Board of Directors (the “Board”). Once increased, such increased amount shall
constitute the Consultant’s Base Compensation.

 

b.Discretionary
Bonus. The Consultant shall be eligible to earn a cash and/or equity bonus as the Board may determine, from time to time,
based on meeting performance objectives and bonus criteria to be mutually identified by the Consultant and the Board. Such objectives
and criteria may be based on a favorable sale or merger of the Company, in additional to operating metrics.

 

    	 	 

    	 

    

 

c.Value
Bonuses. If, during the first twelve (12) months of the initial Term of this Agreement, the volume weighted average price
(“VWAP”) of the Company’s common stock is equal to or greater than $1.00 for each of ten (10) consecutive trading
days on the NYSE MKT exchange, then Consultant shall be entitled to receive a cash bonus in the amount of $250,000 to paid within
thirty (30) days of such triggering event. If, during the first twelve (12) months of the initial Term of this Agreement, the
VWAP of the Company’s common stock is equal to or greater than $2.00 for each of ten (10) consecutive trading days on the
NYSE MKT exchange, then Consultant shall be entitled to receive an additional cash bonus in the amount of $350,000 to paid within
thirty (30) days of such triggering event.

 

3.Expenses:
The Company shall reimburse Consultant for all pre-approved travel and other expenses incurred. Consultant shall provide receipts
and vouchers to the Company for all expenses for which reimbursement is claimed.

 

4.Independent
Contractor: Consultant shall be an independent contractor and no personnel utilized by Consultant in providing services hereunder
shall be deemed an employee of the Company except as otherwise set forth in any written employment agreement. Consultant shall
have the sole and exclusive responsibility and liability for making all reports and contributions, withholdings, payments and
taxes to be collected, withheld, made and paid with respect to persons providing services to be performed hereunder on behalf
of the Company, whether pursuant to any social security, unemployment insurance, worker’s compensation law or other federal,
state or local law now in force and effect hereafter enacted.

 

5.Term:
The term of this Agreement shall commence on the Effective Date and shall continue for twenty-four (24) months, unless earlier
terminated in accordance with the terms hereof. The term of this Agreement shall be automatically renewed for successive one (1)
year periods until the Consultant or the Company delivers to the other party a written notice of their intent not to renew the
term, such written notice to be delivered at least sixty (60) days prior to the expiration of the then-effective term. Each of
the initial 24-month period and each successive one (1) year period shall be known as a “Term.”

 

6.Confidential
Information: Consultant recognizes and acknowledges that by reason of Consultant’s service to the Company before, during
and, if applicable, after the Term, Consultant will have access to certain confidential and proprietary information relating to
the Company’s business, which may include, but is not limited to, trade secrets, trade “know-how,” and plans,
financing services, funding programs, costs, strategy and programs, computer programs and software and financial information (collectively
referred to as “Confidential Information”). Consultant acknowledges that such Confidential Information is a valuable
and unique asset of the Company and Consultant covenants that it will not, unless expressly authorized in writing by the Company,
at any time during the course of Consultant’s service, use any Confidential Information or divulge or disclose any Confidential
Information to any person, firm or corporation except in connection with the performance of Consultant’s duties for the
Company and in a manner consistent with the Company’s policies regarding Confidential Information. Consultant also covenants
that at any time after the termination of such service, directly or indirectly, it will not use any Confidential Information or
divulge or disclose any Confidential Information to any person, firm or corporation, unless such information is in the public
domain through no fault of Consultant or except when required to do so by a court of law, by any governmental agency having supervisory
authority over the business of the Company or by any administrative or legislative body (including a committee thereof) with apparent
jurisdiction to order Consultant to divulge, disclose or make accessible such information. All written Confidential Information
(including, without limitation, in any computer or other electronic format) which comes into Consultant’s possession during
the course of Consultant’s service shall remain the property of the Company. Except as required in the performance of Consultant’s
duties for the Company, or unless expressly authorized in writing by the Company, Consultant shall not remove any written Confidential
Information from the Company’s premises, except in connection with the performance of Consultant’s duties for the
Company and in a manner consistent with the Company’s policies regarding Confidential Information. Upon termination of Consultant’s
service, the Consultant agrees to return immediately to the Company all written Confidential Information (including, without limitation,
in any computer or other electronic format) in Consultant’s possession. As a condition of Consultant’s continued engagement
by the Company and in order to protect the Company’s interest in such proprietary information, the Company shall require
Consultant’s execution of a Confidentiality Agreement and a form reasonably acceptable to the Company.

 

    	 	 

    	 

    

 

7.Non-Competition;
Non-Solicitation.

 

a.Non-Compete.
The Consultant hereby covenants and agrees that during the term of this Agreement and for a period of two years following the
end of the Term, the Consultant will not, without the prior written consent of the Company, directly or indirectly, on its own
behalf or in the service or on behalf of others, whether or not for compensation, engage in any business activity, or have any
interest in any person, firm, corporation or business, through a subsidiary or parent entity or other entity (whether as a shareholder,
agent, joint venture, security holder, trustee, partner, Consultant, creditor lending credit or money for the purpose of establishing
or operating any such business, partner or otherwise) with any Competing Business in the Covered Area. For the purpose of this
Section 7(a), (i) “Competing Business” means any company engaged in acquiring and or monetizing the “Assets”
as defined in the Asset Purchase Agreement (the “Asset Purchase Agreement”) dated of the even date by and among the
Company, MGT Cybersecurity. Inc., D-Vasive Inc. and shareholders of D-Vasive Inc. ; and (ii) “Covered Area” means
all geographical areas of the United States and foreign jurisdictions where the Company may operate. Notwithstanding the foregoing,
the Consultant may own shares of companies so long as such securities do not constitute more than ten percent (10%) of the outstanding
securities of any such company.

 

b.Non-Solicitation.
The Consultant further agrees that as long as the Agreement remains in effect and for a period of one (1) year from its termination,
the Consultant will not divert any business of the Company and or any affiliate of the Company and/or the Company’s and/or
its affiliates’ business to any other person, entity or competitor, or induce or attempt to induce, directly or indirectly,
any person to leave his or her employment with the Company.

 

    	 	 

    	 

    

 

c.Remedies.
The Consultant acknowledges and agrees that its obligations provided herein are necessary and reasonable in order to protect the
Company and its affiliates and their respective business and the Consultant expressly agrees that monetary damages would be inadequate
to compensate the Company and/or its affiliates for any breach by the Consultant of its covenants and agreements set forth herein.
Accordingly, the Consultant agrees and acknowledges that any such violation or threatened violation of this Section 7 will cause
irreparable injury to the Company and that, in addition to any other remedies that may be available, in law, in equity or otherwise,
the Company and its affiliates shall be entitled to obtain injunctive relief against the threatened breach of this Section 7 or
the continuation of any such breach by the Consultant without the necessity of proving actual damages.

 

8.
Termination. This Agreement shall terminate prior to the expiration of any Term (i) upon termination of the Executive Employment
Agreement between the Company and John McAfee (the “McAfee Agreement”) in accordance with the provisions thereof or
(ii) with or without cause without any penalty in the event the transaction contemplated in the Asset Purchase Agreement does
not close within 120 days of the date of this Agreement.

 

a.
Termination of McAfee Agreement without Cause or for Good Reason. If the McAfee Agreement is terminated by the Company
other than for Cause (as defined therein) or as a result of John McAfee’s death or Permanent Disability (as defined therein),
or if the McAfee Agreement is terminated by Mr. McAfee for Good Reason (as defined therein) prior to its expiration date, Consultant
shall receive or commence receiving as soon as practicable in accordance with the terms of this Agreement:

 

(i)
a severance payment (the “Severance Payment”), which amount shall be paid in a cash lump sum within ten (10) days
of the date of termination, in an amount equal to the higher of the aggregate amount of the Consultant’s Base Compensation
for the then remaining term of this Agreement or twelve times the average monthly Base Compensation paid or accrued during the
three full calendar months immediately preceding such termination;

 

(ii)
expense reimbursement which shall be paid in a lump sum payment within ten (10) days of the date of termination, in an amount
equal Consultant’s reimbursed expenses set forth in Section 3 hereof; and

 

(iii)
payment in respect of compensation earned but not yet paid (the “Compensation Payment”) which amount shall be paid
in a cash lump sum within ten (10) days of the date of termination.

 

    	 	 

    	 

    

 

The
following provisions shall apply in the event compensation provided in Section 8(a) becomes payable to the Consultant:

 

(i)
if the severance compensation provided for in Section 8(a)(ii) above cannot be finally determined on or before the tenth day following
such termination, the Company shall pay to the Consultant on such day an estimate, as determined in good faith by the Company
of the minimum amount of such compensation and shall pay the remainder of such compensation (together with interest at the Federal
short-term rate provided in Section 1274(d)(1)(C)(i) of the Code) as soon as the amount thereof can be determined but in no event
later than the thirtieth day after the Date of Termination. In the event the amount of the estimated payment exceeds the amount
subsequently determined to have been due, such excess shall constitute a loan by the Company to the Consultant payable on the
fifth day after demand by the Company (together with interest at the Federal short-term rate provided in Section 1274(d)(1)(C)(i)
of the Code).

 

(ii)
If the payment of the Total Payments (as defined below) will be subject to the tax (the “Excise Tax”) imposed by Section
4999 of the Code, the Company shall pay the Consultant on or before the tenth day following the Date of Termination, an additional
amount (the “Gross-Up Payment”) such that the net amount retained by the Consultant, after deduction of any Excise
Tax on Total Payments and any federal and state and local income tax and Excise Tax upon the payment provided for by this paragraph,
shall be equal to the Total Payments. For purposes of determining whether any of the payments will be subject to the Excise Tax
and the amount of such Excise Tax, (A) any payments or benefits received or to be received by the Consultant in connection with
a Change in Control of the Company or the Consultant’s termination, whether payable pursuant to the terms of this Agreement
or any other plan, arrangement or agreement with the Company, its successors, any person whose actions result in a Change in Control
of the Company or any corporation affiliated or which, as a result of the completion of transaction causing such a Change in Control,
will become affiliated with the Company within the meaning of Section 1504 of Code (the “Total Payments”) shall be
treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “excess parachute
payments” within the meaning of Section 280G(b)(1) shall be treated as subject to the Excise Tax, unless, in the opinion
of tax counsel selected by the Company’s independent auditors and acceptable to the Consultant, the Total Payments (in whole
or in part) do not constitute parachute payments, or such excess parachute payments (in whole or in part) represent reasonable
compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code either in their entirety or in
excess of the base amount within the meaning of Section 280G(b)(3) of the Code, or are otherwise not subject to the Excise Tax,
(B) the amount of the Total Payments that shall be treated as subject to the Excise Tax shall be equal to the lesser of (I) the
total amount of the Total Payments or (II) the amount of excess parachute payments or benefit shall be determined by the Company’s
independent auditors in accordance with the principles of Section 280G of the Code. For purposes of determining the amount of
the Gross-Up Payment, the Consultant shall be deemed to pay federal income taxes at the highest marginal rate of federal income
taxation in the calendar year in which the Gross-Up Payment is to be made and state and local income taxes at the highest marginal
rate of taxation in the state and locality of the Consultant’s residence on the Date of Termination, net of the maximum
reduction in federal income taxes which could be obtained from deduction of such state and local taxes. In the event the Excise
Tax is subsequently determined to be less than the amount taken into account hereunder at the time of termination of the Consultant’s
service, the Consultant shall repay to the Company at the time the amount of such reduction in Excise Tax is finally determined
the portion of the Gross-Up Payment that can be repaid such that the Consultant remains whole on an after-tax basis following
such repayment (taking into account any reduction in income or excise taxes to the Consultant from such repayment) plus interest
on the amount of such repayment at the Federal short-term rate provided in Section 1274(d)(1)(C)(i) of the Code. In the event
the Excise Tax is determined to exceed the amount taken into account hereunder at the time of the termination of the Consultant’s
service (including by reason of any payment the existence or amount of which cannot be determined at the time of the Gross-Up
Payment), the Company shall make an additional gross-up payment in respect of such excess (plus any interest payable with respect
to such excess) at the time that the amount of such excess is finally determined.

 

    	 	 

    	 

    

 

(iii)
This Agreement is intended to comply with the requirements of Section 409A of the Internal Revenue Code (the “Code”)
or an exemption or exclusion therefrom. Each payment under this Agreement shall be treated as a separate payment for purposes
of Section 409A of the Code. In no event may Consultant, directly or indirectly, designate the calendar year of any payment to
be made under this Agreement. All reimbursements and in-kind benefits provided under this Agreement that constitute deferred compensation
within the meaning of Section 409A of the Code shall be made or provided in accordance with the requirements of Section 409A of
the Code, including, without limitation, that (i) in no event shall reimbursements by the Company under this Agreement be made
later than the end of the calendar year next following the calendar year in which the applicable fees and expenses were incurred,
provided that Consultant shall have submitted an invoice for such fees and expenses at least 10 days before the end of the calendar
year next following the calendar year in which such fees and expenses were incurred; (ii) the amount of in-kind benefits that
the Company is obligated to pay or provide in any given calendar year (other than medical reimbursements described in Treas. Reg.
§ 1.409A-3(i)(1)(iv)(B)) shall not affect the in-kind benefits that the Company is obligated to pay or provide in any other
calendar year; (iii) Consultant’s right to have the Company pay or provide such reimbursements and in-kind benefits may
not be liquidated or exchanged for any other benefit; and (iv) in no event shall the Company’s obligations to make such
reimbursements or to provide such in-kind benefits apply later than Consultant’s remaining lifetime or if longer, through
the 20th anniversary of the Effective Date. To the extent Consultant is a “specified employee,” as defined in Section
409A(a)(2)(B)(i) of the Code and the regulations and other guidance promulgated thereunder and any elections made by the Company
in accordance therewith, notwithstanding the timing of payment provided in any other Section of this Agreement, no payment, distribution
or benefit under this Agreement that constitutes a distribution of deferred compensation (within the meaning of Treasury Regulation
Section 1.409A-1(b)) upon separation from service (within the meaning of Treasury Regulation Section 1.409A-1(h)), after taking
into account all available exemptions, that would otherwise be payable, distributable or settled during the six-month period after
separation from service, will be made during such six-month period, and any such payment, distribution or benefit will instead
be paid, distributed or settled on the first business day after such six-month period; provided, however, that if Consultant dies
following the Date of Termination and prior to the payment, distribution, settlement or provision of the any payments, distributions
or benefits delayed on account of Section 409A of the Code, such payments, distributions or benefits shall be paid or provided
to the personal representative of Consultant’s estate within 30 days after the date of Consultant’s death.

 

    	 	 

    	 

    

 

b.Termination
of McAfee Agreement as a Result of Permanent Disability. If the McAfee Agreement is terminated by reason of Permanent Disability
as defined therein, the Consultant shall receive or commence receiving, as soon as practicable, the Compensation Payment which
shall be paid to Consultant as a cash lump sum within 30 days of such termination.

 

c.
Termination of McAfee Agreement as a Result of Death. In the event that the McAfee Agreement terminates as a result of
death, the Consultant shall receive or commence receiving, as soon as practicable in accordance with the terms of this Agreement:

 

(i)
compensation equal to one year’s Base Compensation (calculate by multiplying the average monthly Base Compensation paid
or accrued for the three full calendar months immediately such event), which shall be paid within 30 days of such termination;
and

 

(ii)
the Compensation Payment which shall be paid as a cash lump sum within 30 days of such termination.

 

d.Termination
of McAfee Agreement by the Company for Cause or by McAfee other than for Good Reason. In the event that the McAfee Agreement
is terminated by Company for Cause, as defined therein, or by Mr. McAfee other than for Good Reason as defined therein, the Consultant
shall be entitled only to receive, as a cash lump sum within 30 days of such termination, the Compensation Payment earned as of
the date of such termination.

 

9.Change
In Control. If a Change in Control of the Company, as defined in the McAfee Agreement, occurs during the Term, the Consultant
shall be entitled to the compensation provided in Section 8(a) of this Agreement upon the subsequent termination of this Agreement
by either the Company, or the Consultant within two years of the date upon which the Change in Control shall have occurred, unless
such termination is a result of termination of the McAfee Agreement as a result of (i) death; (ii) Disability; (iii) Retirement;
or (iv) Cause.

 

    	 	 

    	 

    

 

10.Assignment.
This Agreement shall be binding upon and inure to the benefit of the successors, assigns, and representatives of Consultant
and the assigns and successors of Company, but neither this Agreement nor any rights or obligations hereunder shall be assignable
or otherwise subject to hypothecation by Consultant (except by will or by operation of the laws of intestate succession or by
Consultant notifying the Company that cash payment be made to an affiliated investment partnership in which Consultant is a control
person) or by Company, except that Company may assign this Agreement to any successor (whether by merger, purchase or otherwise)
to all or substantially all of the stock, assets or businesses of Company, if such successor expressly agrees to assume the obligations
of Company hereunder.

 

11.Indemnification.
Consultant shall be indemnified by the Company against all liability incurred by the Consultant in connection with any proceeding,
including, but not necessarily limited to, the amount of any judgment obtained against Consultant, the amount of any settlement
entered into by the Consultant and any claimant with the approval of the Company, attorneys’ fees, actually and necessarily
incurred by him in connection with the defense of any action, suit, investigation or proceeding or similar legal activity, regardless
of whether criminal, civil, administrative or investigative in nature (“Claim”), to which it is made a party or is
otherwise subject to, by reason of its being or having been an agent of, or consultant to, the Company, to the full extent permitted
by applicable law and the Certificate of Incorporation of the Company. Such right of indemnification will not be deemed exclusive
of any other rights to which Consultant may be entitled under Company’s Certificate of Incorporation or By-laws, as in effect
from time to time, any agreement or otherwise.

 

12.General
Provisions.

 

a.Modification:
No Waiver. No modification, amendment or discharge of this Agreement shall be valid unless the same is in writing and signed
by all parties hereto. Failure of any party at any time to enforce any provisions of this Agreement or any rights or to exercise
any elections hall in no way be considered to be a waiver of such provisions, rights or elections and shall in no way affect the
validity of this Agreement. The exercise by any party of any of its rights or any of its elections under this Agreement shall
not preclude or prejudice such party from exercising the same or any other right it may have under this Agreement irrespective
of any previous action taken.

 

b.Notices.
All notices and other communications required or permitted hereunder or necessary or convenient in connection herewith shall be
in writing and shall be deemed to have been given when hand delivered or mailed by registered or certified mail as follows (provided
that notice of change of address shall be deemed given only when received):

 

    	 	 

    	 

    

 

If
to the Company, to:

 

MGT
Capital Investments, Inc.

500
Mamaroneck Avenue, Suite 320

Harrison,
NY 10528

 

If
to Consultant, to:

 

Future
Tense Secure Systems, Inc.

216
S. 8th St.

Opelika,
AL 36801

Attn:
Tom Guscinski, President

 

Or
to such other names or addresses as the Company or Consultant, as the case may be, shall designate by notice to each other person
entitled to receive notices in the manner specified in this Section.

 

c.Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.

 

d.
Further Assurances. Each party to this Agreement shall execute all instruments and documents and take all actions as may
be reasonably required to effectuate this Agreement.

 

e.Severability.
Should any one or more of the provisions of this Agreement or of any agreement entered into pursuant to this Agreement be determined
to be illegal or unenforceable, then such illegal or unenforceable provision shall be modified by the proper court or arbitrator
to the extent necessary and possible to make such provision enforceable, and such modified provision and all other provisions
of this Agreement and of each other agreement entered into pursuant to this Agreement shall be given effect separately from the
provisions or portion thereof determined to be illegal or unenforceable and shall not be affected thereby.

 

f.Successors
and Assigns. Consultant may not assign this Agreement without the prior written consent of the Company. The Company may assign
its rights without the written consent of the Consultant, so long as the Company or its assignee complies with the other material
terms of this Agreement. The rights and obligations of the Company under this Agreement shall inure to the benefit of and be binding
upon the successors and permitted assigns of the Company, and the Consultant’s rights under this Agreement shall inure to
the benefit of and be binding upon its successors. The Company’s subsidiaries and controlled affiliates shall be express
third party beneficiaries of this Agreement.

 

    	 	 

    	 

    

 

g.Entire
Agreement. This Agreement supersedes all prior agreements and understandings between the parties, oral or written. No modification,
termination or attempted waiver shall be valid unless in writing, signed by the party against whom such modification, termination
or waiver is sought to be enforced.

 

h.Counterparts;
Facsimile. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be
an original, and all of which taken together shall constitute one and the same instrument. This Agreement may be executed by facsimile
with original signatures to follow.

 

IN
WITNESS WHEREOF, Company and Consultant have duly executed this Agreement as of the day and year first above written.

 

	CONSULTANT:
    Future Tense Secure Systems Inc.	 	MGT
    CAPITAL INVESTMENTS, INC.
	 	 	 
	 	 	 
	Name:
    Tom Guscinski	 	Name:
    Robert B. Ladd
	Title:
    President	 	Title:
    CEO and President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}]]